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9ABSTRACT
Unexplained infertility, refering to the failure to conceive of a couple in whom 
no deﬁ nitive cause for infertility can be found, has an incidence of 10-20% in 
all infertile couples. The purpose of this study was to examine the impedance 
to uterine blood ﬂ ow, different treatments and obstetric outcome in unexplained 
infertility.
Main uterine and spiral artery impedance to blood ﬂ ow was compared in 20 
women with unexplained and 18 women with tubal infertility. Measurements were 
taken both during the natural cycle (on days 11-12, 16-17 and 21-23) and during 
the in-vitro fertilization (IVF) treatment cycle (on days 1, 5, 10, ovum pick-up 
and embryo transfer). The mean uterine artery impedance was below three in 
women with unexplained infertility during the natural and IVF cycles, and no 
signiﬁ cant differences were observed between the groups. The mean impedance 
(± SD) in spiral arteareries was lower (pulsatility index 0.96 ± 0.25) in women 
with unexplained infertility on day 5 of gonadotrophin stimulation compared with 
women with tubal infertility (pulsatility index 1.24 ± 0.30; p<0.05).
The main uterine artery impedance to blood ﬂ ow was studied among 102 
women during 111 conceptional IVF cycles. The aetiology of infertility was 
either unexplained, tubal, endometriosis or multifactorial. Predicting obstetric 
complications with measurement of uterine artery impedance among these women 
was not possible. The mean uterine artery pulsatility index (PI) was comparable in 
pregnancies leading to spontaneous abortion (PI 2.71 ± 0.67), ectopic pregnancy 
(PI 2.36 ± 0.54) and normal intra-uterine pregnancy (PI 2.69 ± 0.71).
Seventy women with unexplained infertility were treated with ovulation induction 
combined with intra-uterine insemination, direct intraperitoneal insemination and 
timed intercourse, and these treatments were equally effective.
The same seventy women were followed for six years after completed ovulation 
induction treatment. In all, 64% of these couples conceived during the follow-up, 
with the majority (60%) of pregnancies beginning spontaneously. In spontaneous 
pregnancies, both the mean birthweight (3387 g vs. 3120 g) and the relative 
birthweight were signiﬁ cantly higher than in treatment pregnancies.
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      One hundred and seven women with unexplained infertility who conceived 
with in-vitro fertilization treatment were studied. Two control groups (n=445 
and n=2377) were chosen from the Finnish Medical Birth Register. The rate of 
spontaneous abortion was 24% and the multiple pregnancy rate was 23%,  including 
one triplet pregnancy. No difference was found in mean birthweight, incidence 
of low birthweight, gestational duration, umbilical artery pH and rate of major 
congenital malformations in women with unexplained infertility as compared 
with normally conceived or IVF pregnancies.  The rate of pregnancy-induced 
hypertension was signiﬁ cantly lower among singletons in the study group compared 
with other IVF singletons.
No difference was observed in uterine artery impedance when women with 
unexplained infertility and women with tubal infertility were compared. Predicting 
pregnancy outcome with measurement of uterine artery impedance during IVF 
treatment was not possible. Ovulation induction was an effective treatment for 
women with unexplained infertility. Obstetric outcome among women with 
unexplained infertility was good, being similar to that of spontaneous pregnancies 
and IVF pregnancies.
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I INTRODUCTION
Infertility, deﬁ ned as failure to conceive within one year despite normal cohabitation 
(Zabrek 1996; Barbieri 1996) or within two years according to the European Society 
for Human Reproduction and Embryology (Forti and Krausz 1998), presents in 
10-15% of all couples. Typically, 80% of couples (aged 18-28 years) will conceive 
over a one-year period and another 10% conceive during the following year. The 
rate of infertility has slowly been increasing (Stephen and Chandra 1998; Silverberg 
2000).
While many of these couples will conceive with assisted reproductive technology 
(ART), about 20% will never conceive. The ﬁ rst artiﬁ cial insemination was reported 
in 1799 in the United Kingdom. In-vitro fertilization (IVF) was developed more than 
one century later, and the ﬁ rst IVF baby was born in 1978 in the United Kingdom 
(Steptoe and Edwards 1978). In Finland, the ﬁ rst IVF baby was born in 1984 at the 
Helsinki University Central Hospital (Koskimies et al. 1984). ART has subsequently 
become an effective and widely used therapy for childless couples (Wikland et al. 
1985). Approximately 7200 embryo transfers are performed in Finland each year, 
and more than 10 000 IVF babies have been born since 1984 (Nygren and Nybo 
Andersen 2001). Of all newborn babies, about 2.6% are born as the result of IVF 
treatment compared with 1.3% in other European countries. More than half of all 
IVF cycles world-wide are provided in Europe, mostly in France, United Kingdom 
and Germany (Nygren and Nybo Andersen 2001). During IVF treatment trans-
vaginal ultrasound is an essential tool for monitoring follicular growth and 
performing ovum pick-up. Since the mid-1980s, when transvaginal ultrasound 
gained popularity among gynaecologists, its image quality and diagnostic accuracy 
in infertility and many other gynaecological conditions have improved dramatically. 
The Colour Doppler method has enabled non-invasive evaluation of pelvic and 
foetal blood ﬂ ow, which is useful in different pathological conditions.
IVF has revolutionalized the treatment of infertile couples, as well as profoundly 
increasing the basic understanding of human reproduction. Treatment options and 
results today are promising in most subgroups of infertility, including unexplained 
infertility, where IVF is used both as a diagnostic and therapeutic tool.
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II REVIEW OF THE LITERATURE
1. INFERTILITY
The incidence of infertility is approximately 10-15% (Lilford and Dalton 1987; 
Templeton et al. 1991; Crosignani et al. 1996). Primary infertility refers to the 
condition of an infertile woman who has never conceived, and secondary infertility 
to one who has had a previous pregnancy. At present, almost 80% of infertile 
couples can be helped to have a child. The incidence of voluntary infertility is very 
low, approximately below 3% (Templeton et al. 1991).
Reasons for the increasing incidence of infertility include postponement of 
childbearing, increased pelvic infections and, in some countries, deteriorating 
sperm quality (Unkila-Kallio 2001). The reasons for infertility are related to female 
factors, male factors, to a combination of the two or to unknown causes, each 
comprising 25%. The most frequent causes for infertility are ovulatory disorder or 
anovulation, tubal factor, abnormal semen parameters, endometriosis and uterine or 
cervical factor (Table 1; Jaffe and Jewelewicz 1991; Collins et al. 1995). Less common 
causes for infertility are immunological factors and genetic defects. Smoking also 
decreases the ability to conceive (Stillman et al. 1986; Mueller and Daling 1989). 
Infertility in many couples has multiple aetiologies; however, in approximately 
15-17% of  couples, no reason for infertility is found and the infertility is deﬁ ned as 
unexplained (Templeton and Penney 1982; Collins et al. 1995; Aboulghar et al. 2001).
Table 1. Most frequent causes of infertility (Jaffe and Jewelewicz 1991; Collins et al. 1995).
_______________________________________________
Cause of infertility %
_______________________________________________
Ovulatory disorder or anovulation 27-30
Tubal factor 20-22
Abnormal semen parameter 25-40
Unexplained 15
Endometriosis 5
Uterine or cervical factor 4-5
_______________________________________________
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2. UNEXPLAINED INFERTILITY
2.1. Deﬁ nition and incidence
Unexplained infertility, sometimes also called idiopathic infertility, refers to failure 
to conceive in a couple for whom no deﬁ nitive cause for infertility can be found. 
Usually, the duration of infertility is more than two years (Jaffe and Jewelewicz 
1991; Crosignani et al. 1993; Aboulghar et al. 2001). The incidence of unexplained 
infertility varies in different studies but is usually 10-20% (Templeton and Penney 
1982; Crosignani et al. 1993; Guzick et al. 1994, 1998; Lessey et al. 1995; Miller et al. 
1999).  Incidence depends on the selection and age of the study population and, 
to some extent, on infertility evaluations. Unexplained infertility is not an absolute 
condition but a relative inability to conceive, and while many of these couples may 
conceive without treatment, treatment will often hasten conception (Fish et al. 
1989).
The diagnosis is possible only after a complete infertility evaluation, including 
a physical examination of both partners, has been performed (Templeton and 
Penney 1982; Jaffe and Jewelewicz 1991). The basic infertility work-up includes 
demonstration of 1) ovulation and normal luteal phase, 2) patent fallopian tubes and 
3) normal ﬁ ndings in semen analysis according to the World Health Organization 
(WHO; Guzick et al. 1994; Forti and Krausz 1998). However, the recommended basic 
infertility evaluation varies among different practitioners and no consensus exists 
on which investigations are the most appropriate (Forti and Krausz 1998; Kelly et 
al. 2001).
Ovulation is indicated by the existence of a regular menstrual cycle (26-32 days, 
with the cycle length varying no more than 4 days from cycle to cycle), an ovulatory 
progesterone rise at midcycle and a luteal phase of ≥12 days (Jaffe and Jewelewicz 
1991). Different cut-off values indicative of ovulation are progesterone levels >16 
nmol/l (Crosignani et al. 1993), >18 nmol/l at two assays (Forti and Krausz 1998) or 
>25 nmol/l in midluteal phase (Miller et al. 1999).
Tubal patency is determined by ultrasound-assisted hysterosalpingosonography 
(HSSG), hysterosalpingography (HSG) or, if necessary, laparoscopy and 
chromopertubation (Heikkinen et al. 1995; Forti and Krausz 1998). The agreement 
of HSSG with HSG is 84-94% (Spalding et al. 1998, 1999). When comparing HSSG 
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with laparoscopy in evaluation of tubal patency, results are consistent in 76-93% 
of women (Allahbadia 1992, Stern et al. 1992; Spalding et al. 1997). There is also a 
75% correlation with ﬁ ndings in HSG and laparoscopy (Jaffe and Jewelewicz 1991). 
Laparoscopy is indicated if the woman has suffered from pelvic inﬂ ammatory 
disease (PID), if endometriosis is suspected in cases of dysmenorrea or dyspareunia, 
or if the woman has previously undergone many abdominal operations such as 
complicated appendicectomy (Forti and Krausz 1998). Assessment of tubal patency 
is unnecessary if IVF or intracytoplasmic sperm injection (ICSI) is indicated, as in 
cases of severe male infertility (Forti and Krausz 1998).
Based on the WHO criteria for normality, a sperm concentration of ≥ 20 million/ml, 
motility of ≥ 50% and normal morphology of ≥ 15% are required (World Health 
Organization 1999).
The post-coital test (PCT) has been used to study the sperm-cervical mucus 
interaction,  but the predictive value of PCT is poor because of difﬁ culty in timing 
the test. The test has mostly been abandoned due to poor standardization of the 
technique and differences in interpretation of results (Glatstein et al. 1995; Forti and 
Krausz 1998).
2.2. Speculations on possible underlying causes
Several theories have been tendered on the aetiology of unexplained infertility 
(Table 2). Diminished ovarian reserve, as shown by elevated serum follicle-stimulating 
hormone (FSH) level, may be one cause (Cahill et al. 1995; Blacker et al. 1997; 
Luborsky et al. 2000) and can result in alterations to other hormonal levels. One 
study revealed that 5% of women with unexplained infertility had elevated FSH 
levels in the early follicular phase (Rodin et al. 1994). Changes in LH levels, 
a low FSH/LH ratio and reduced LH concentration in follicular ﬂ uid have also been 
speculated to play a role in unexplained infertility (Cahill et al. 1995; Omland et al. 
2001). FSH and LH abnormalities may reﬂ ect a dysfunction on the pituitary-ovarian 
axis (Leach et al. 1997; Omland et al. 2001). Both the serum estradiol levels in 
follicular phase and the E2/P ratio have been shown to be elevated in women with 
unexplained infertility, suggesting altered folliculogenesis (Blacker et al. 1997; Leach 
et al. 1997) and an absent midcycle elevation of the hormone prolactin, which is 
present in fertile women (Subramanian et al. 1997).
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Table 2. Theories about the aetiology of unexplained infertility.
_________________________________________________________________________________________________
Theory/Clinical ﬁ nding Mechanism Study_________________________________________________________________________________________________
Pituitary and/or follicular dysfunction
FSH elevation diminished ovarian reserve Blacker et al. 1997
LH fall impaired follicular development Omland et al. 2001
poor ovulation  impaired/ short luteal phase Rodin et al. 1994;
  Blacker et al. 1997
oestrogen elevation altered folliculogenesis Blacker et al. 1997;
  Leach et al. 1997
abnormal prolactin absent mid-cycle prolactin rise and Subramanian et al. 1997
 impaired oocyte development
pituitary-ovarian  impaired follicular development Cahill et al. 1995
dysfunction
impaired follicular impaired ovulation and Blacker et al. 1997
development increased risk of LUF Omland et al. 1998
Gamete dysfunction
Oocyte dysfunction
decreased oocyte function reduced oocyte quality Blacker et al. 1997;
  Omland et al. 2001
impaired oocyte transport impaired ovum pick-up and Ahmad-Thabet 2000
 impaired tubal transport Omland et al. 1998
impaired oocyte-sperm impaired fertilization Blacker et al. 1997;
interaction  Omland et al. 2001
 
Sperm dysfunction
impaired penetration of impaired fertilization Hull et al. 1998
cervical mucus
impaired penetration of impaired fertilization Takeuchi et al. 2000;
zona pellucida  Hull et al. 1998
  
impaired penetration of impaired fertilization Takeuchi et al. 2000;
ooplasmic membrane  Hull et al. 1998
Alterations in endometrial function
subclinical infection impaired implantation Kundsin et al. 1987
  
suboptimal expression of impaired endometrial Omland et al. 2001
integrins and pinopods development and
 switch in the window of Lessey et al. 1995
 implantation
Immunological factors
elevated concentrations of:
ovarian antibodies ovarian failure Luborsky et al. 2000
anti-spermatozoal  impaired fertilization Luborsky et al. 2000
antibodies
anti-cardiolipin increased uterine artery Battaglia et al. 1998
antibodies resistance
_________________________________________________________________________________________________
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Another possible explanation is an impaired luteal phase, with a shorter luteal 
phase or a decreased peak serum progesterone level (Li et al. 1990; Guzic et 
al. 1994; Blacker et al. 1997; Leach et al. 1997). Impaired luteal phase has been 
demonstrated in about 30% of women with unexplained infertility. Among women 
aged 40-45 years, the rate of impaired luteal phase is higher than among women 
aged 20-29, as is also the incidence of unexplained infertility (Rodin et al. 1994; 
Miller et al. 1999). Both increased and decreased follicular LH-pulse frequency and a 
lower FSH/LH ratio or decreased midfollicular FSH have been postulated to induce 
impaired luteal phase, which may primarily be due to a functional imbalance in the 
hypothalamus (Nakajima and Gibson 1991).
Besides hormonal factors, gamete dysfunction may contribute to unexplained 
infertility. Altered folliculogenesis, impaired oocyte maturation, reduced oocyte 
quality and defects in gamete interaction have all been suggested (Gabrielsen et al. 
1996; Blacker et al. 1997; Omland et al. 2001). A sperm dysfunction would impair 
the ability of spermatozoa to penetrate the cervical mucus, the zona pellucida and 
the ooplasmic membrane (Hull et al. 1998; Takeuchi et al. 2000). An insufﬁ cient 
acrosome reaction could cause a fertilization failure, which is sometimes seen in IVF 
(Esterhuizen et al. 2001). In addition, genetic defects may affect success rates of IVF 
among women with unexplained infertility. Total failure of fertilization is reported 
in 5-30% of the cycles in conventional IVF among these women, which is more 
frequent than among other subgroups (Gürgan et al. 1995; Ruiz et al. 1997; 
Takeuchi et al. 2000). One theory suggests that a failure in the natural ovum pick-
up mechanism by the fallopian tube may occur in these women, although this is 
difﬁ cult to verify (Ahmad-Thabet 2000).
Altered endometrial function may be another cause of unexplained infertility 
(Kleintzeris 1997). A subacute inﬂ ammation may be present as differences have 
been observed between fertile and infertile women in endometrial leucocyte 
populations (Kundsin et al. 1987; Viniker 1999). Low endometrial progesterone 
receptor concentrations, inadequate estrogenic induction of progesterone receptors, 
decreased inhibin levels (Nakajima and Gibson 1991) and suboptimal expression 
of integrins or pinopode formation in the endometrium have also been reported 
in women with unexplained infertility (Kleintzeris 1997; Garcia-Velasco and Arici 
1999; Nikas et al. 1999; Omland et al. 2001).
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Ovarian antibodies are frequent (33%) in some reports among women with 
unexplained infertility (Geva et al. 1997; Luborsky et al. 1999, 2000), as are 
elevated antispermatozoal (Luborsky et al. 2000; Szczepanska et al. 2001) and 
anticardiolipin antibodies; the antibody levels have been shown to correlate 
with uterine artery resistance (Battaglia et al. 1998). Moreover, an inadequate 
maternal immunosuppression, which might cause embryo rejection in women with 
unexplained infertility, has been suspected (Kleintzeris 1997). The prevalence of 
coelic disease is also higher among women with unexplained infertility compared 
with both the general population and other infertile women (Meloni et al. 1999), 
which may be due to the elevated antibody levels found in their tissues.
Unexplained infertility may also be functionally linked to endometriosis since many 
women with unexplained infertility later develop endometriosis (Cahill et al. 1995; 
Guzick et al. 1998; Hull et al. 1998). Furthermore, occupational exposure to noise, 
chemicals, radiation, mercury and cadmium may be linked to unexplained infertility 
(Mueller and Daling 1989). Women’s anxiety and stress levels may also lower the 
chances of conception (Sarell et al. 1985).
Abnormal uterine artery blood ﬂ ow might be associated with unexplained infertility 
(Goswamy et al. 1988; Kupesic and Kurjak 1993; Steer et al. 1994). Increased uterine 
artery impedance in midluteal phase or an abnormal ﬂ ow in spiral arteries would 
impair the implantation process, and have been suggested as possible mechanisms 
for infertility (Kupesic and Kurjak 1993; Steer et al. 1994).
2.3. Treatment options
Different treatment options in unexplained infertility include: a) expectant 
management, b) clomiphene citrate (CC), or c) gonadotrophins used for ovulation 
induction, d) intra-uterine insemination (IUI), e) ovulation induction with CC or 
gonadotrophins combined with IUI or direct intraperitoneal insemination (DIPI) 
and f) in-vitro fertilization and its modiﬁ cations.
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Expectant management
Couples with unexplained infertility have a chance of spontaneous conception. 
With expectant management, the pregnancy rate per cycle is estimated to be 
0.9-4.1% (Collins et al. 1995; Guzick et al. 1998; Donderwinkel et al. 2000; Goverde 
et al. 2000). Observation can be offered if the woman is under 28-30 years and the 
infertility duration is less than 2-3 years (Crosignani et al. 1993; Forti and Krausz 
1998).  About 14-20% of all couples with unexplained infertility will conceive 
without treatment within one year and 25-30% within two years (Eimers et al. 1994; 
Collins et al. 1995). The cumulative three-year pregnancy rate without treatment is 
30-80% (Hull et al 1985; Guzick et al. 1998) and the ﬁ ve-year cumulative pregnancy 
rate is 80% (Randolph 2000). Moreover, a life table analysis showed that as many 
as 64% of primary and 79% of secondary unexplained infertility patients conceived 
within nine years (Jaffe and Jewelewicz 1991).
 Ovulation induction with clomiphene citrate
Clomiphene citrate is usually used for ovulation induction. CC has been shown to 
increase pregnancy rate from 1-2% to 5% per cycle in women with unexplained 
infertility (Hughes et al. 2001).
Ovulation induction with gonadotrophins
When gonadotrophins are used, a low starting dose (50-75 IU) for ovulation 
induction is usually recommended (Goverde et al. 2000), and the dose is adjusted 
according to ovarian response (Salha and Balen 2000). The ovarian response 
and follicular count and size are monitored with serial ultrasound and serum E2 
measurements (Nachtigall and Schwartz 1996; Sahakyan et al. 1999). Treatment 
results of ovulation induction are shown in Table 3.
Intra-uterine insemination
Intra-uterine insemination in the spontaneous cycle is an alternative ﬁ rst choice 
of treatment of women with unexplained infertility (Goverde et al. 2000). After 
standard swim-up or Percoll gradient preparation of the semen, a catheter is passed 
through the cervical canal and the washed sperm suspension at volumes of 0.5-
19
2 ml is expelled into the uterine cavity (Nuojua-Huttunen et al. 1999a). This can be 
combined with CC and/or gonadotrophins (Fisch et al. 1989; Forti and Krausz 1998; 
Guzic et al. 1998; Lacin et al. 2001). DIPI in combination with ovulation induction 
has also been shown to signiﬁ cantly improve pregnancy rates (Crosignani et al. 
1991). However, as DIPI is more invasive than IUI and the pregnancy rates are equal, 
IUI is usually preferred (Hovatta et al. 1990).
In-vitro fertilization
In-vitro fertilization is recommended for treatment of couples with unexplained 
infertility when other treatments have failed (Forti and Krausz 1998; Ola et al. 
Table 3. Cycle fecundity rate in couples with unexplained infertility treated with ovulation 
induction combined with intra-uterine insemination or intercourse.
__________________________________________________________________________________________________________________________________________
 Number of Number of Treatment protocol Pregnancy rate Study
 women treatment cycles  (% per cycle)
__________________________________________________________________________________________________________________________________________
 155 564 CC/ CC+hMG/ hCG/placebo Fisch et al. 1989
  241 COH + IUI 27.4 Crosignani et al. 1991
 
 268 463 CC + hMG + IUI x 1-2 20.1 Aboulghar et al. 1993
 50 130 GnRHa + FSH 150 IU + hCG 5000  21.8 Chung et al. 1995
   IU + hCG 2000 IU (luteal support) 
   + IUI x 2
 50 110 GnRHa + FSH 150 IU + hCG 5000  7.7 Chung et al. 1995
   IU + hCG 2000 IU (luteal support) 
   + TI x 2
 117 284 11.0 Tadokoro et al. 1997
 40 40 30.0 Zayed et al. 1997
 351 351 CC + hCG + IUI 10.0 van der Westerlaken 
     et al.  1998
  315 CC + IUI 6.7 Guzic et al. 1998
  1133 hMG + IUI 18
 119 119 CC 100mg + hMG/ FSH 75-150  33.6 Omland et al. 1998
   
   or
   hMG/ FSH + hCG 10.000 IU + IUI x1-2
 97 97 hMG/FSH 150-225 IU + hCG  10 Sahakyan et al. 1999
   5-10.000 IU + IUI x 2
  413 CC/ hMG + IUI 15.3 Nuojua-Huttunen 
     
__________________________________________________________________________________________________________________________________________
IU + hCG 10.000 IU + IUI x 1-2
hMG/ FSH + hCG 
CC + FSH+ hCG + IUI + hCG 
19 / 7.6 / 11 / 0 
et al. 1999 a
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2001). IVF is useful for detecting abnormalities in gametes and for evaluating the 
fertilizing capacity of spermatozoa and oocytes. If no fertilization has occurred in 
a previous IVF attempt, intracytoplasmic sperm injection (ICSI) is the treatment of 
choice, as also in cases of low fertilization percentage with conventional IVF.
Gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) are 
variations of IVF.  Their ﬁ rst indication was unexplained infertility (Asch et al. 
1986), and they were used in the 1980s and 1990s. These treatments required 
similar stimulation as IVF, patent fallopian tubes and earlier also laparoscopic 
approach (Crosignani et al. 1993). As both these treatments were more invasive and 
expensive and offered no advantages compared with IVF, they have largely been 
abandoned (Randolph 2000). The oviduct was thought to provide an optimized 
environment for fertilization and ﬁ rst cell divisions, and the embryo was thought 
to enter the uterine cavity at a more physiological time in the luteal phase than 
in IVF (Boatman 1997; Guzic et al. 1998). However, GIFT does not allow the 
determination of fertilization and neither technique permits the assessment of 
embryonic development (Randolph 2000).
Reported pregnancy rates with GIFT are 27-55%, and delivery rate per retrieval 
29-34% per treatment cycle (Trounson and Wood 1993; Hull et al. 1994; Guzick 
1998). With ZIFT, the pregnancy rates are 32-48% (Guzic et al. 1998; Randolph 
2000). One reason for good pregnancy rates in GIFT as compared with IVF in some 
studies may be the greater number of oocytes transferred, resulting in an increased 
rate of multiple pregnancies (Cohen 1991). No prospective, large-scale, randomized 
studies have proved GIFT and ZIFT to be superior to IVF.
 
3. Ultrasound examination
3.1. Basic
In vaginal ultrasound, the typical operating frequency is 5-7.5 MHz, which enables 
good image quality within 8-12 cm from the transducer (Dickey 1997). In abdominal 
probes, the operating frequency is generally 3.5 MHz, which gives deeper tissue 
penetration at lower frequencies and enables examination of inner structures 
(Dickey 1997). The pioneering investigators developed transvaginal ultrasound 
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to study follicular growth and enable easy oocyte retrieval (Dellenbach et al. 
1984; Meldrum et al. 1984; Schwimer and Lebovic 1984; Wikland et al. 1985). 
The use of transvaginal ultrasound later expanded to include other gynaecological 
applications. Transvaginal ultrasound is an important tool for studying the anatomy 
and pathology of the uterus and ovaries of infertile women. With ultrasound 
examination of the uterus, uterine ﬁ broids, endometrial polyps, Asherman’s syndrome 
and different developmental uterine anomalies, such as bicornuate uterus and septate 
uterine conﬁ guration, can be detected (Allahbadia 1992; Zabrek 1996). When studying
the ovaries, polycystic ovaries, endometriomas, pyo- and hydrosalpinx and tubo-
ovarian abscesses can be recognized (Allahbadia 1992; Zabrek 1996). Ultrasound 
has also increased our basic knowledge of follicular growth and endometrial 
development, and is essential for monitoring both natural and induced cycles.
3.2. Doppler ultrasound
Because the evaluation of quantitative blood ﬂ ow on the basis of blood ﬂ ow 
velocity waveform is difﬁ cult various qualitative indices have been introduced. 
These are the systolic/diastolic (S/D) ratio, the pulsatility index (PI), the resistance 
index (RI), also called Pourcelot’s ratio, and peak systolic velocity (PSV). Uterine 
artery resistance is measured by S/D, PI and RI.
SD= systolic/diastolic ratio
PI=   S/D    
     
  mean
RI=   S/D    
          
S
The measurement of PI requires computer-assisted calculation of mean velocity. 
The RI approaches 1.00 when diastolic velocities are abnormally low. Both high PI 
and RI reﬂ ect impairment of ﬂ ow and are independent of insonating angle and true 
velocity. The PI and RI are highly correlated.
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Colour Doppler sonography is useful in identifying blood vessels and enables study 
of blood ﬂ ow characteristics of small vessels within the endometrium and the ovary. 
Colour Doppler sonography facilitates study of branching of the uterine vasculature 
from main uterine arteries to radial and spiral arteries in the endometrium. Apart 
from the location, each of the vessels can be recognized by a characteristic 
waveform pattern. Colour Doppler sonography uses lower sound intensity than 
grey-scale ultrasound. It is an indispensable tool for studying ectopic pregnancy, 
molar pregnancy and gynaecological tumours. Power Doppler, also called Doppler 
power spectrum analysis, uses echo amplitude (intensity) in the analysis and is 
independent of angle (Harman 1995).
3.3. Doppler ultrasound during natural and IVF cycles
Doppler ultrasound during natural cycle
The highest uterine artery PI values occur on day 1 of the menstrual cycle, when 
a mean PI of 4.6 has been shown (Steer et al. 1990; Sladkevicius et al. 1994). The 
uterine artery PI is also high 2-3 days after the LH peak (Steer et al. 1990; Sladkevicius 
et al. 1993). Many studies have shown that the lowest impedance-to-ﬂ ow in the 
uterine artery in the spontaneous menstrual cycle occurs in the luteal phase, 6-12 
days after the LH peak, which coincides with the implantation window during 
cycle days 19-25 (Steer et al. 1990; Sladkevicius et al. 1993; Tan et al. 1996; 
Bloechle et al. 1997; Ziegler et al. 1999; Chek et al. 2000). Some studies have 
reported a correlation between plasma estradiol and PI and an inverse correlation 
between plasma progesterone and PI (Steer et al. 1990). Another study demonstrated 
that a high PI in the follicular phase was associated with low estradiol and 
progesterone, but no association was observed between serum estradiol and 
progesterone levels and uterine artery PI in the luteal phase (Tinkanen et al. 1994). 
Other studies have not found any correlation between serum estradiol and uterine 
artery impedance (Steer et al. 1994; Zaidi et al. 1995; Ziegler et al. 1999).
In midluteal phase, uterine artery PI is typically below 3.0 and RI below 0.90 
(Cacciatore 1996c). Fertility is usually affected when the uterine artery resistance 
during midluteal phase is increased and when normal haemodynamic changes 
in uterine artery impedance do not occur (Steer et al. 1994; Tinkanen et al. 
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1994; Coulam et al. 1999; Ziegler et al. 1999). Therefore, 20-40% of infertile 
women have a high PI (>3.0) in luteal phase, which earlier was associated with 
a poorer chance of conception (Steer et al. 1994; Cacciatore et al. 1996a; 
Cacciatore 1996c). Uterine artery impedance reﬂ ects the impedance of the whole 
uterine vascular bed and may be affected by many factors such as ﬁ broids, 
adenomyosis and uterine contractility. The uterine artery resistance in the luteal 
phase is also shown to be elevated in different infertile subgroups (Kurjak 
et al. 1991; Tinkanen et al. 1994; Zaidi et al. 1998). The explanation for this ﬁ nding 
among women with anovulatory cycles is a subnormal hormonal concentration 
(Kurjak et al. 1991, Tinkanen et al. 1994), among women with polycystic ovaries 
(PCO) an elevated androgen concentration (Zaidi et al. 1998), and among women 
with endometriosis or chronic PID peritoneal scarring (Tinkanen and Kujansuu 
1992; Steer et al. 1994; Tinkanen et al. 1994). Besides these subgroups, it has 
been suggested that abnormal uterine perfusion may also be a contributing factor 
to unexplained infertility (Coulam et al. 1994; Steer et al. 1994). However, one 
study showed that the mean uterine artery PI in the midluteal phase did not 
differ signiﬁ cantly when comparing women with unexplained infertility, women 
with adhesions due to PID and women with moderate or severe endometriosis 
(Tinkanen et al. 1994).
Besides infertility, some factors may also increase uterine artery impedance in fertile 
women. Levonorgestrel intrauterine device (IUD) increases the uterine artery PI in 
fertile women during the luteal phase, whereas the copper IUD has no effect on 
uterine artery blood ﬂ ow (Järvelä et al. 1998a, 1998b).
In addition, vascular perfusion of the uterus is known to decrease and uterine 
artery impedance to increase during menopause, mainly as a result of declining 
estradiol concentrations (Goswamy et al. 1988; Battaglia et al. 1995; Kurjak and 
Kupesic 1995). About 50% of postmenopausal women have a decreasing PSV in 
uterine arteries and 10% have an absent or reversed diastolic ﬂ ow (Sladkevicius et 
al. 1994). Furthermore, the uterine arteries become smaller, the shape of the blood 
ﬂ ow velocity waveform changes and the uterine artery becomes more difﬁ cult 
to visualize (Sladkevicius et al. 1994). Many studies have shown that estradiol 
treatment in postmenopausal women reduces uterine artery impedance (de Ziegler 
et al. 1991; Pirhonen et al. 1993; Järvelä et al. 1997). However, synthetic progestins 
may antagonize the vasodilatory effect in uterine arteries induced by estrogen 
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treatment (Pirhonen et al. 1993; Järvelä 1998c). Results of different studies have 
been conﬂ icting as to the effect of adding progesterone to HRT and its inﬂ uence 
on uterine artery impedance (de Ziegler et al. 1991; Bonilla-Musoles et al. 1995). 
Interestingly, some studies report no decrease in uterine perfusion with age (Chek 
et al. 2000).
Doppler ultrasound during IVF cycle
Transvaginal ultrasound is essential in monitoring ovulation induction cycles and 
IVF cycles to determine the number and size of developing follicles during 
gonadotrophin stimulation. The uterine artery impedance is usually lower in 
gonadotrophin-stimulated cycles compared with natural cycles, and the PI of 
uterine arteries on the day of ET is lower in stimulated than in spontaneous cycles 
(Tekay et al. 1996a). Early studies showed promising results where uterine artery PI 
on day of ET was lower in conception than in non-conception cycles (Steer et al. 
1990, 1995; Cacciatore et al. 1996a). In a study by Steer et al. (1995), for example, 
the median PI (range) was 2.85 (1.4-3.6) in conception and 4.15 (2.1-6.8) in non-
conception FET cycles (p<0.01). Similar ﬁ ndings were found by Cacciatore et al. 
(1996a), who reported a mean PI (± SD) of 2.45 (± 0.54) in conception and 2.66 
(± 0.39) in non-conception cycles (p<0.05) during IVF treatment. Different cut-off 
values have been suggested to predict non-conception in the IVF cycle. Coulam 
et al. (1994) found a uterine artery PI>3.3, and Steer et al. (1994) and Cacciatore 
(1996c) reported a uterine artery PI >3.0, whereas Favre et al. (1993) reported a 
PI>3.55 to predict non-conception. Tekay and co-workers found a nonsigniﬁ cant 
increase in receptivity when the uterine artery PI was between 2.0 and 2.99 and 
suggested that a cut-off value of PI>4.0 would predict a non-conception cycle 
(Tekay et al. 1995, 1996b). Furthermore, the uterine receptivity is found to be poor 
when no end diastolic ﬂ ow in uterine artery is detected (Goswamy et al. 1988; 
Kurjak et al. 1991; Steer et al. 1992; Coulam et al. 1994; Cacciatore et al. 1996a; 
Tekay et al. 1996a; Tan 1999). Women with absent end diastolic ﬂ ow or poor uterine 
blood ﬂ ow have been shown to also have an increased risk of spontaneous abortion 
(Cacciatore 1996c). In natural cycles with FET, the implantation has been shown to 
decrease when PI>3.5 or with absent end diastolic velocities (Cacciatore 1996c).
Estradiol levels are generally much higher during IVF cycle than natural cycles 
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(Tekay et al. 1996a). Gonadotrophin stimulation with elevated estradiol levels 
has been shown to decrease uterine artery PI by approximately 20% (Cacciatore 
1996c). During IVF an inverse correlation has been shown between uterine artery 
PI values and estradiol levels (Weiner et al. 1993; Cacciatore and Tiitinen 1996b).
Nevertheless, according to current knowledge, it is not possible to distinguish 
between conception and non-conception cycles with the sole measurement of 
uterine artery PI and RI (Favre et al. 1993; Coulam et al. 1994; Bassil et al. 1995; Tekay 
et al. 1995, 1996a). Many factors make comparison of the results difﬁ cult. Different 
study populations, different stimulation protocols, small size of study populations, 
an overlap of measured PI values when comparing conception and non-conception 
cycles, diurnal variation in uterine artery blood ﬂ ow in the periovulatory period, 
showing a lower PI early in the morning, and different results when examining 
uterine blood ﬂ ow in women standing and in recumbent position (Coulam et 
al. 1994; Dickey et al. 1994; Zaidi et al. 1995; Tekay et al. 1996b). In conclusion, 
measurement of uterine artery impedance during IVF treatment to predict outcome 
of treatment is not useful in routine clinical practice.
Uterine artery impedance during pregnancy
Efforts have been made to predict pregnancy complications by uterine artery 
measurements. Blood ﬂ ow velocity in the uteroplacental arteries increases and the 
PI decreases linearly with advancing gestation, indicating an exponential increase 
in uterine arteries and uterine perfusion during the ﬁ rst trimester (Valentin et al. 
1996). Some studies have shown that uterine and spiral artery resistance were 
lower at the end of the ﬁ fth week in blighted ovum pregnancies (Alﬁ revic and 
Kurjak 1990) and the uterine artery RI was lower in missed abortion than in 
women with normal pregnancies (Alﬁ revic and Kurjak 1990; Kurjak 1994). Another 
study showed that uterine artery PI measurement at 12-13 weeks of gestation 
could predict subsequent hypertensive disorders, small-for-gestational-age fetuses 
and gestational diabetes during pregnancy (van den Elzen et al. 1995). In contrast 
to these studies uterine artery RI measurements during the ﬁ rst trimester of 
pregnancy have not in other studies predicted miscarriage or normal delivery 
(Frates et al. 1996).
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The uterine artery mean ﬂ ow velocity rises progressively from a non-pregnant 
value nearly eightfold by week 36 (Palmer et al. 1992). By measuring uteroplacental 
and umbilical artery Doppler S/D ratios during the 24th gestational week, it was 
possible to predict intrauterine growth retardation and hypoxia (Newnham et al. 
1990). Another study suggested that uterine artery measurement at 21-24 weeks 
could predict PIH and IUGR in high-risk but not low-risk populations (Zimmermann 
et al. 1997). Numerous other studies have also shown that measurement of uterine 
artery blood ﬂ ow is useful in predicting pre-eclampsia or fetal growth restriction 
(Bewley et al. 1991; Strigini et al. 1995; Harrington et al. 1996; Kurdi et al. 1998).
With advancing gestation, the spiral artery RI decreases in normal pregnancies 
(Murakoshi et al. 1996). An abnormal spiral artery RI has been proven to have 
better diagnostic accuracy than the RI of uterine artery waveform for predicting 
PIH and IUGR, and in one study with 43 pregnancies complicated with PIH and/ or 
IUGR, 19 had abnormal spiral artery RI when examinations were performed during 
gestational weeks 18-41 (Murakoshi et al. 1996).
Impedance in spiral artery
In healthy fertile women, a signiﬁ cant decrease in spiral artery resistance occurs 
from the proliferative to the luteal phase, and the changes are equivalent to those 
seen in uterine arteries (Kurjak and Kupesic 1995). Because the sensitivity of colour 
Doppler is limited, weak vascular signals in endometrial vasculature can be difﬁ cult 
to observe (Yang et al. 1999). However, endometrial blood ﬂ ow has been suggested 
to be a more speciﬁ c parameter for predicting uterine receptivity in IVF cycles 
than uterine blood ﬂ ow, and when endometrial blood ﬂ ow is poor, implantation 
is less likely to occur (Zaidi et al. 1995; Tan 1999). In 88.8% of infertile patients, 
spiral arteries can be demonstrated during the natural cycle from day 10-12 
onwards (Kupesic 1996b). However, not all studies have found predictive value 
of measurements of subendometrial PI (Yuval et al. 1999). The absence of 
subendometrial ﬂ ow on day of HCG administration during the IVF cycle has 
been shown to predict failure of implantation irrespective of the morphological 
appearance of the endometrium (Zaidi et al. 1995). Spiral artery impedance 
measurement has greater inter-observer variability compared with that of uterine 
arteries (Dickey et al. 1994). Levonorgestrel IUD has been shown to suppress the 
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formation of spiral arteries (Järvelä 1998c). Age also affects spiral artery blood ﬂ ow. 
With advancing age, blood ﬂ ow to the endometrium decreases and blood ﬂ ow in 
spiral arteries is detected in only 30% of postmenopausal women within 1-5 years 
of cessation of the menstrual cycle (Kurjak and Kupesic 1995).
A surprising ﬁ nding is that better perfusion of the uterus, measured as lower PI 
values both in the radial and spiral arteries in the natural cycle compared with 
corresponding values in ovulation induction cycles, suggests that receptivity of the 
uterus would be better in natural cycles (Kupesic and Kurjak 1993).
Most authors agree that treatment cycles with absent spiral arteries have poor 
implantation rates. Despite some initially promising results in predicting conception 
and non-conception cycles with measurement of spiral artery impedance in women 
with detectable spiral arteries, some studies show no difference in spiral artery 
impedance measurement in conception and non-conception cycles; therefore, 
further research is clearly needed.
Impedance in ovarian artery
In ovarian arteries, the cyclic variations are smaller than in uterine arteries (Tekay 
et al. 1995). In natural cycles, the ovarian artery RI has been shown to decline on 
the day before ovulation and to remain low in the luteal phase both in healthy 
and infertile women (Kurjak et al. 1991; Tinkanen et al. 1994; Kupesic et al. 1995). 
Intrafollicular PSV has also been demonstrated to increase on the day of ovulation 
and remain high for at least 72 hours (Campbell et al. 1993). This increases blood 
supply to the corpus luteum, which is important for steroidogenesis and favours 
implantation and early embryo development (Kupesic 1996a). The ovarian PI on 
the dominant side is signiﬁ cantly lower and PSV signiﬁ cantly higher in the luteal 
phase in the ovarian stroma and hilus (Sladkevicius et al. 1993). An increased intra-
ovarian impedance has been found in patients with out-of-phase endometrium 
biopsies thoughout the luteal phase, since among menopausal women and later in 
menopause, no blood ﬂ ow can be detected in the ovaries (Sladkevicius et al. 1994; 
Kurjak and Kupesic 1995).
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Cyclic alterations in ovarian artery blood ﬂ ow seen in natural cycles do not occur 
in gonadotrophin-stimulated cycles, where arteries seem maximally dilated (Tekay 
et al. 1995). In IVF cycles, no difference has been found in ovarian artery impedance 
when comparing conception and non-conception cycles (Sterzic et al. 1989; Tekay 
et al. 1995). According to a recent study, a follicle with high PSV in a natural or IVF 
cycle will most likely have a good oocyte with high implantation potential (Kelly et 
al. 2001). However, the role of ovarian blood ﬂ ow in successful IVF treatment has 
yet to be studied in larger study populations.
 
4. Assisted reproductive technology
4.1. Deﬁ nition and rate of success
Assisted reproductive technology (ART) includes controlled ovarian stimulation 
alone or combined with intra-uterine insemination or direct intraperitoneal 
insemination and in-vitro fertilization and its modiﬁ cations. The success rates of 
treatment vary considerably with patient selection, infertility duration, indication 
for treatment and type of treatment.
Ovarian stimulation and/or artiﬁ cial insemination (IUI/DIPI)
Ovarian stimulation with CC or gonadotrophins increases the levels of gonadal 
steroids as a result of development of multiple pre-ovulatory follicles and may 
overcome subtle ovulatory defects, such as luteinized unruptured follicle syndrome, 
not detected in routine diagnostic studies; pregnancy rate may increase with the 
larger number of oocytes available for fertilization (Fish et al. 1989; Guzic et al. 1998; 
Aboulghar et al. 1999; Sahakyan et al. 1999). Swim-up of sperm before insemination 
may enhance the fertilizing capacity of sperm, and increase the density of motile 
sperm in the uterus and fallopian tubes available for fertilization and implantation 
(Aboulghar et al. 1999). By IUI or DIPI, problems in cervical mucus, mild defects in 
sperm motility and function are overcome (Crosignani and Rubin 1996; Wolf 2000). 
By bringing together multiple mature oocytes and highly motile sperm in the fallopian 
tube, the likelihood of pregnancy is increased (Fish et al. 1989). 
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Although couples with unexplained infertility usually have ovulatory cycles even 
without treatment, ovulation induction may overcome subtle defects in ovulatory 
function not detected in conventional tests, and increase the number of oocytes 
available for fertilization and implantation (Guzic et al. 1998; Aboulghar et al. 
1999; Sahakyan et al. 1999). CC has also been shown to reduce the incidence of 
luteal-phase deﬁ ciency from 31% to 3% among women with unexplained infertility 
(Rodin et al. 1994).
IUI in the spontaneous cycle among women with unexplained infertility yields 
pregnancy rates of 2.4-7.4% per cycle (Guzic et al. 1998; Goverde et al. 2000); 
which is similar to pregnancy rates of expectant management (Goverde et al. 2000). 
If CC is used without IUI, the pregnancy rate per cycle is 4-5.6% among women 
with unexplained infertility (Guzic et al. 1998; Hughes et al. 2001). The use of 
gonadotrophins (hMG) alone is associated with a pregnancy rate of 7.7% (Guzic 
et al. 1998). If CC is used in combination with IUI, the pregnancy rate per cycle is 
approximately 8.3% (Guzic et al. 1998). If CC or hMG is used in combination with 
IUI, the pregnancy rate per cycle increases to approximately 10-17.1% and 29.8%, 
respectively, per patient after three treatment cycles (Guzic et al. 1998; Aboulghar 
et al. 1999; Sahakyan et al. 1999).
In-vitro fertilization
IVF is now recommended for essentially all infertility conditions that have not been 
successfully treated by other modalities (Dor et al. 1996; Forti and Krausz 1998; 
Unkila-Kallio 2001). IVF is useful for recognizing abnormalities in gametes and for 
evaluating the fertilizing capacity of spermatozoa and oocytes, i.e. we know whether 
the sperm penetrate and fertilize the oocytes. This is especially important among 
couples with unexplained infertility or male infertility. Figure 1 shows the treatment 
protocol for IVF.
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Figure 1. A model for ovarian hyperstimulation for IVF with long pituitary 
downregulation with a GnRH agonist.   The squares in the ﬁ gure represent days of 
stimulation.
The reason for the favourable success rate in IVF is partly the same as in COH, i.e. 
it increases the production of a superabundance of oocytes with superovulation 
which are then available for fertilization, overcomes ovulatory defects and 
enhances fertilizing ability (Guzic et al. 1998; Hull et al. 1998). Furthermore, IVF is 
useful for documenting the occurrence of fertilization and for evaluating embryo 
quality.
The pregnancy rates are almost equally good in all indications. Couples with 
unexplained infertility treated with IVF usually have the same oocyte recovery as 
other groups, but they have been shown to have reduced fertilization and cleavage 
rates, and a complete failure of fertilization has been reported in 5-30% of the cycles 
(Hull et al. 1998; Takeuchi et al. 2000). However, the complete fertilization failure is 
usually not repetitive (Hull et al. 1998). New evidence points to the possibility of 
oocyte metaphase I maturation block, which is responsible for at least part of the 
repetitive fertilization failures (Harrison et al. 2000; Bergere et al. 2001).
Among women with unexplained infertility treated with IVF, clinical pregnancy 
rates per oocyte pick-up (OPU) are 21-37% (Crosignani et al. 1991; Tanbo et al. 1995; 
Guzic et al. 1998; Aboulghar et al. 1999). The overall reported cumulative pregnancy 
rates among unselected patients undergoing IVF treatment are 22-32% after one, 
36-57% after two, 47-71% after three and 53-81% after four IVF attempts (Rowlands 
et al. 1994; Stolwijk et al. 2000). The reported corresponding cumulative birth rates 
are 29%, 52%, 63% and 75%, respectively (Rowlands et al. 1994).
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4.2. Prognostic markers for successful outcome
Many investigators have tried to ﬁ nd predictive markers for successful outcome of 
IVF treatment. Traditionally, the woman’s age and early follicular phase serum FSH 
are the most useful parameters for prediction of ovarian reserve (Chek et al. 1994; 
Kupesic and Kurjak 2002). The most important predictive factor for success in IVF 
treatment in many studies is age of the woman. The highest livebirth rates after IVF 
are equivalent in both age group 25-30 years (Templeton et al. 1996) and in age 
group below 35 years (Abdelmassih et al. 1996; Engmann et al. 2001). Conception 
rates begin to decline at 30-33 years due to oocyte and endometrial aging 
(Battaglia et al. 1996; Dor et al. 1996; Lim and Tsakok 1997). Another study reported 
declining pregnancy rates after IVF-ET with increasing female age as follows: in 
women aged <30 years, clinical pregnancy rate 29.4%; in women 30-35 years, 
19.8%; in women 36-39 years, 17.1%; in women >40 years, 12.8% (Szamatowicz and 
Grochowski 1998). With increasing age, the number and quality of oocytes decline, 
a larger proportion of the oocytes remain unfertilized in IVF and the pregnancy 
rates tend to be lower (Lim and Tsakok 1997). After the mid-thirties, follicles also 
have fewer granulosa cells, thus producing less steroids and glucoproteins, and 
decreased mitosis and increased apoptosis appear (Nikolaou et al. 2002). Female 
age is also of important prognostic value in gonadotrophin-induced COH-IUI cycles 
(Buyalos et al. 1997; Sahakyan et al. 1999). Increased early follicular phase FSH and 
E2 values have been shown to correlate with poor ovarian reserve and reduced 
fertility potential in COH treatment cycles (Magarelli et al. 1996; Buyalos et al. 
1997). Elevated FSH has been suggested to induce enhanced E2 production by 
granulosa cells (Buyalos et al. 1997).
Besides female age, the cause of infertility may also inﬂ uence the outcome of 
ART treatment; couples with unexplained infertility are reported to have a better 
prognosis than couples with tubal infertility or endometriosis (Templeton et al. 
1996; Omland et al. 1998; Nuojua-Huttunen et al. 1999a; Sahakyan et al. 1999). 
Women with tubal infertility have also been reported to have lower cumulative 
delivery rates than other subgroups of infertility (Sundström et al. 1997). Among 
women with tubal infertility, a relationship exists between grade of tubal damage 
and pregnancy rate following IVF. Patients with milder tubal damage have higher 
take-home baby rates per started IVF cycle (48%) than patients with severe tubal 
damage (6%; Csemiczky et al. 1996). The pregnancy rates of infertile women with 
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hydrosalpinx are signiﬁ cantly lower (19.7%) than those of women with tubal 
infertility without hydrosalpinx (31.2%; Camus et al. 1999). One study showed that 
women with endometriosis had a higher and couples with male factor infertility a 
lower pregnancy rate after IVF than in other aetiologies of infertility (Minaretzis et 
al. 1998). In addition, women with ovulatory disorders or endometriosis have also 
been reported to have good pregnancy rates compared with male and tubal factor 
infertility in COH-IUI treatment cycles (Sahakyan et al. 1999). However, some other 
studies have not shown any difference in pregnancy rate after IVF when comparing 
different subgroups of infertile patients (Tan et al. 1992; Dor et al. 1996).
The duration of infertility and parity of women inﬂ uence pregnancy rates in ART. 
An increase in duration of infertility decreases the chance of success after IVF 
treatment (Templeton et al. 1996) and COH-IUI cycles (Nuojua-Huttunen et al. 
1999a). In COH-IUI cycles, an infertility duration of over six years has been shown to 
decrease the chance of success (Tomlinson et al. 1996; Nuojua-Huttunen et al. 1999a). 
A previous pregnancy and delivery, especially if the earlier pregnancy was achieved 
after IVF treatment, increases the chance of success in a subsequent IVF treatment 
(Templeton et al. 1996; Engmann et al. 2001). Patients with secondary infertility 
have been reported to have nearly double the pregnancy rate of women with 
primary infertility (Lessing et al. 1988; Collins and Rowe 1989). On the other hand, 
the highest livebirth pregnancy rate is reported in the ﬁ rst three treatment cycles 
(Engmann et al. 2001). Another study showed that the clinical pregnancy rate 
remained similar during the ﬁ rst six IVF cycles (Dor et al. 1996). A recent study 
revealed that the following factors increased the chance of success in the IVF cycle: 
age of woman (<35 years), previous IVF live birth, other than tubal infertility, large 
number of embryos created and fewer than three previous unsuccessful IVF cycles 
(Engmann et al. 2001).  All of these factors increase the chance of both singleton 
and multiple births (Engmann et al. 2001).
An ideal method to predict uterine receptivity has yet to be established (Friedler 
et al. 1996). Furthermore, the overall success rate of the clinic is very important 
when predicting success for a particular couple (Templeton et al. 1996). According 
to recent studies, major determinants of successful in-vitro fertilization besides 
woman’s age are embryo quality, number of embryos transferred and endometrial 
thickness (Goverde et al. 2000; Bassil 2001).
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Embryo quality is largely based on cleavage rate and the degree of fragmentation, 
which are important factor in predicting implantation (Ziebe et al. 1997; Alikani 
et al. 1999). Lundin et al. (2001) showed that embryos which cleave early, i.e. 
complete the ﬁ rst mitotic division within 25-27 hours post-insemination, provide 
higher pregnancy per transfer rate (40.5% vs. 31.5%; p=0.0049) than slower-cleaving 
embryos (van Royen et al. 1999). Furthermore, the rate of twin pregnancies has 
been found to be higher (33.3% vs. 22.3%; p=0.036), and the rate of spontaneous 
abortion to be lower in the early-cleaving group (Lundin et al. 2001). Unevenly 
cleaved embryos with large differences in blastomere size have higher rate 
of aneuploidy and lower implantation rates than embryos with equally sized 
blastomeres (Hardarson et al. 2001).
The presence of large fragments is detrimental to the developing embryo and 
these embryos have signiﬁ cantly lower pregnancy rates, whereas small fragments 
do not affect implantation (Alikani et al. 1999). It is possible to score embryos 
in IVF cycles, and according to this scoring, decide how many embryos should 
be transferred. A top-quality embryo is characterized by the presence of 4 or 5 
blastomeres on day 2 and at least 7 blastomeres on day 3 after insemination, the 
absence of multinucleated blastomeres and <20% cellular fragments on day 2 and 
day 3 after fertilization (Gerris and van Royen 2000). By transferring only one top-
quality embryo in the ﬁ rst IVF/ICSI cycle of women <34 years of age, a prospective 
study showed that the implantation rate was 42.3%, and thus, the pregnancy rate 
was similar or even better compared with normal fertile couples (Te Velde and 
Cohlen 1999). Moreover, this procedure limited the twin pregnancy rate to <1% 
of pregnancies (Gerris and van Royen 2000). The number of normally developed 
embryos, i.e. the number of embryos available for transfer, is more important 
in determining the probability of birth than the number of embryos actually 
transferred (Engmann et al. 2001). In contrast, the risk of multiple gestation 
increased both with the number of embryos available and the number of embryos 
transferred (Engmann et al. 2001). Also, if several embryos are created, it increases 
the likelihood of selecting good-quality embryos for transfer, thus, the number of 
embryos available may be an indirect measure of embryo quality (Devreker et al. 
1999; Engmann et al. 2001). The cell stage at transfer of the embryo is also important 
in predicting success of treatment (Yang et al. 1999; Bassil 2001).
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The type of embryo transfer catheter has also been shown to inﬂ uence pregnancy 
rates, which in a recent study were signiﬁ cantly higher with a soft catheter 
compared with a stiff catheter (27.1% vs. 20.5%; van Weering et al. 2002).
Studies have shown that a small ovarian volume, reduced stromal area and decreased 
number of antral follicles predict poor response in controlled ovarian stimulation 
(Chek et al. 1994; Syrop et al. 1995; Pellicer et al. 1998; Kupesic and Kurjak 
2002). A strong association between ovarian volume and ovarian reserve has been 
demonstrated, and measurement of ovarian volume was recommended as an 
essential part of infertility evaluation (Lass et al. 1997). A cut-off value of less than 
3 cm3 may reﬂ ect failure to respond to gonadotrophin stimuli (Lass et al. 1997). 
However, when measured with three dimensional ultrasound, it was shown that 
some patients may have diminished ovarian reserve without changes in ovarian 
volume (Kupesic and Kurjak 2002). Other authors suggested that predicting ovarian 
response was possible by counting the number of antral follicles (Tomas et al. 
1997). The best predictive factor for ovarian response to stimulation is in fact 
assessment of the total number of antral follicles by ultrasound (Ng et al. 2000; 
Kupesic and Kurjak 2002). The number of antral follicles is clearly related to 
reproductive age and reﬂ ects the remaining primordial follicle pool (Kupesic and 
Kurjak 2002). Measurement of ovarian stromal PSV in early follicular phase may also 
predict follicular response (Zaidi et al. 1995). Poor responders have been shown to 
have a poor ovarian stromal PSV (Zaidi et al. 1995).
Measurements of the intra-endometrial power Doppler area (Yang et al. 1999) have 
been postulated to predict implantation. According to another study, however, 
the three-dimensional power Doppler measurement of the endometrial area is not 
helpful in predicting implantation (Kupesic et al. 2001). Nevertheless, in a study 
of 56 infertile women, statistically signiﬁ cant differences were shown in the antral 
follicle number, ovarian volume, ovarian stromal area and ovarian stromal ﬂ ow 
index in conception and non-conception cycles when ovaries were studied after 
pituitary suppression during IVF treatment (Kupesic and Kurjak 2002).
Uterine artery impedance has previously been demonstrated to predict conception 
in IVF cycles, but it is an inaccurate method and no consensus on a cut-off rate for 
good pregnancy rates exists. However, most authors agree that an absent end diastolic 
ﬂ ow on day of ET predicts non-conception during the present IVF cycle (Goswamy 
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et al. 1988; Kurjak et al. 1991; Steer et al. 1992; Coulam et al. 1994; Cacciatore 
et al. 1996a; Tekay et al. 1996b; Tan 1999).
The endometrium is thicker in ART cycles compared with natural cycles mainly 
due to higher E2 levels in ART cycles (De Geyter et al. 2000). No differences were 
found in endometrial thickness between conception and non-conception cycles 
during  ART treatment (Coulam et al. 1994; Bohrer et al. 1996; De Geyter et al. 
2000), although cut-off values of 6-8 mm have been suggested as the minimum 
for embryo implantation (Steer et al. 1992; Coulam et al. 1994; Zaidi et al. 1995). 
A multilayer endometrial pattern has also been shown to predict conception in 
ovulation induction cycles (Check et al. 1991; Coulam et al. 1994; Seraﬁ ni et al. 1994; 
Hock et al. 1997). In addition, a conversion of the endometrial pattern from the 
homogeneous pattern seen in the early proliferative phase to the trilaminar pattern 
must occur to produce optimal receptivity (Zaidi et al. 1995; Hock et al. 1997). 
A pre-ovulatory triple-line endometrium combined with end diastolic velocity in 
the ﬁ rst branch of uterine artery was the most important predictor of conception in 
one study (Seraﬁ ni et al. 1994). However, endometrial thickness and morphological 
appearance of the endometrium are rather inaccurate methods for predicting 
conception, and evaluation of morphological appearance is quite subjective (Tan 
1999; Kupesic et al. 2001). Furthermore, measurements of spiral artery impedance 
to predict conception have given inconsistent results (Zaidi et al. 1995; Schild 
et al. 2001). Most authors do, however, agree that absent spiral arteries predicts 
non-conception during the present IVF cycle (Zaidi et al. 1995; Yang et al. 1999).
4.3. Pregnancy outcome of ART-induced pregnancies
The rate of spontaneous abortions is approximately 19-25% after IVF, and this rate 
is similar to that of women with normal fertility (Wilcox et al. 1999; Pezeshki et 
al. 2000; Gissler and Tiitinen 2001). No association has been shown between the 
aetiology of infertility and the risk of spontaneous abortion after IVF (Pezeshki et 
al. 2000). The risk of spontaneous abortion is similar in IVF and ICSI pregnancies 
(Govaerts et al. 1996; Gissler and Tiitinen 2001), but results of other studies are 
conﬂ icting (Aytoz et al. 1999; Grifﬁ ths et al. 2000; Ola 2000; Bonduelle et al. 2002). 
Bleeding, particularly in the ﬁ rst trimester, is more common in IVF pregnancies 
than in spontaneous pregnancies (Olivennes et al. 1993; Verlanen et al. 1995; 
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Wennerholm et al. 1996; Koudstaal et al. 2000a).
The rate of ectopic pregnancies after IVF is reported to be 2-4%, and the 
corresponding ﬁ gure after natural conception is 2% (Marcus et al. 1995; Strandell 
et al. 1999; Adamsson and Brzyski 2000). Tubal infertility, tubal surgery and PID 
increase the risk to 7-10% after IVF treatment, while male factor infertility has 
a protective effect against ectopic pregnancy (Verlust et al. 1993; Strandell et 
al. 1999). Among IVF pregnancies, the rate of heterotopic pregnancies is <1.0% 
(Ludwig et al. 2001).
A period of infertility of more than 12 months signiﬁ cantly increases the woman’s 
risk of preterm birth (1.6- to 1.8-fold) and a low birth weight baby (1.9-fold) even 
in the absence of infertility treatment (Williams et al. 1991; Henriksen et al. 1997).
COH-IUI treatment has been reported to reduce the mean birthweight of newborns 
compared with spontaneous pregnancies (Nuojua-Huttunen et al. 1999b). Another 
study showed increased risk of non-insulin-dependent diabetes mellitus (12.7% 
vs. 6.9%), pregnancy-induced hypertension (9.3% vs. 6.2%) and Caesarean section 
(18.4% vs. 13.1%) after COH treatment compared with spontaneous pregnancies 
(Maman et al. 1998). Moreover, a small increase in the rate of preterm birth after 
COH-IUI or donor insemination has been reported (Wang et al. 2002).
The risk of pregnancy-induced hypertension, pre-eclampsia, placenta previa and 
non-insulin-dependent gestational diabetes increase in IVF-pregnancies, also among 
singletons (Wennerholm et al. 1991; Doyle et al. 1992; Tan et al. 1992; Wang et 
al. 1994; Tallo et al. 1995; Tanbo et al. 1995; Maman et al. 1998; Minakami et al. 
1998; Hansen et al. 2002), but some authors have suggested that these increased 
risks are associated with patient characteristics, such as increased maternal age and 
lower parity (Doyle et al. 1992; Lansac 1995; Wennerholm et al. 1996). Pregnancies 
achieved after IVF also increase the risk of premature deliveries and low birthweight 
also in singleton pregnancies (Bergh et al. 1999; Tarlatzis and Grimbizis 1999; 
Westergaard et al. 1999; Hansen et al. 2002; Schieve et al. 2002; Wang et al. 
2002). On average, IVF singletons were born 5.1 days earlier and weighed 
214 grams less than spontaneously conceived infants (Koudstaal et al. 2000a). 
A signiﬁ cant increase in rate of low birthweight babies has been shown both among 
preterm and full-term singletons (Schieve et al. 2002). The risk of low birthweight 
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infants is estimated to be 2.6-fold that of the general population (Schieve et al. 
2002). In singleton pregnancies, the rate of preterm delivery is approximately 9-15% 
in IVF vs. 3-6% in spontaneously conceived pregnancies (Maman et al. 1998; Tarlatzis 
and Grimbizis 1999), the rate of low birthweight newborns (<2500 g) is 13.4% vs. 
7.3% (Tarlatzis and Grimbizis 1999; Koudstaal et al. 2000a) and the rate of very low 
birthweight newborns (<1500 g) is approximately 2.6% (Tan et al. 1992; Olivennes 
et al. 1993; Schieve et al. 2002) vs. 1% (Hansen et al. 2002). Low birthweight is 
less common in infants conceived with ICSI treatment due to male factor infertility 
compared with other subgroups (Schieve et al. 2002). In comparing IVF and ICSI 
pregnancies, statistically signiﬁ cant differences have been seen in the rate of very 
low birthweight infants (IVF 5.6% vs. ICSI 4.4%), whereas the rate of preterm birth 
was signiﬁ cantly higher in ICSI pregnancies (Bonduelle et al. 2002). Many reports 
also show an elevated rate of Caesarean section among both singleton and multiple 
pregnancies after IVF, as well as increased induction of labour in unselected IVF 
patients (Verlanen et al. 1995; Maman et al. 1998; Westergaard et al. 1999).
Studies among women with unexplained infertility have shown an especially high 
risk of IUGR after ART compared with other subgroups (Wang et al. 1994; Dawood 
1996). Also signiﬁ cantly higher incidences of pre-eclampsia, placental abruption, 
preterm labour, induction of labour and emergency Caesarean section have been 
demonstrated among women with unexplained infertility compared to the general 
population (Pandian et al. 2001). In addition, spontaneous pregnancies among these 
women had elevated rates of obstetric complications.
Pregnancies achieved after IVF bear an increased risk of multiple pregnancy, the 
rate of multiple pregnancy being approximately 25-35% (Koudstaal et al. 2000b; 
Nygren and Nyboe Andersen 2001; Tiitinen et al. 2001), compared with only 1% 
in naturally conceived pregnancies (Addor et al. 1998). Multiple pregnancy is, 
according to many authors, the most serious complication of ART (Vilska et al. 
1999; Tiitinen et al. 2001; Koivurova et al. 2002). The risk of multiple pregnancy 
is related to the number of embryos transferred and not to IVF per se. Multiple 
pregnancies, either conceived spontaneously or after IVF, increase the risk of many 
complications, the most important being low birthweight infants (Koudstaal et 
al. 2000b). IVF twins have also higher rates of very low birthweight, discordant 
birthweight, prematurity, neonatal morbidity and mortality and women with IVF 
twins have an elevated risk of vaginal bleeding compared with women with 
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spontaneously conceived twins (Bernasko et al. 1997; Moise et al. 1998; Koudstaal 
et al. 2000b). However, in some studies, twins conceived with ART did not have an 
increased rate of low birthweight compared with spontaneously conceived twins 
(Westergaard et al. 1999; Schieve et al. 2002).
In most earlier studies, the incidence of congenital and chromosomal anomalies 
after IVF and ICSI has been comparable to that in the general population, 
approximately 1.8-4.5% (Lancaster et al. 1995; Govaerts et al. 1996; Palermo et 
al. 1996; Wennerholm et al. 1996; Johnson 1998; Tarlatzis and Grimbizis 1999; 
Westergaard et al. 1999; Ludwig et al. 2001; Bonduelle et al. 1996, 1999, 2002). 
No statistically signiﬁ cant difference has been observed in major malformation 
rates when ICSI and IVF children were compared (Bonduelle et al. 2002). In some 
studies higher rates, such as 7.6% congenital malformations after ICSI, have been 
reported (4.1% were classiﬁ ed as major; Wennerholm et al. 2000).  And a recent 
report from Australia showed an increased rate of major congenital anomalies after 
IVF (9.0%) and ICSI (8.6%), compared with 4.2% for naturally conceived infants 
(Hansen et al. 2002). Signiﬁ cantly increased rates of cardiovascular, urogenital, 
musculoskeletal and chromosomal defects were demonstrated among infants 
conceived with IVF, and musculoskeletal and chromosomal defects among infants 
conceived with ICSI. The reason for these ﬁ ndings may be the relatively small 
number of patients included in the latter study as well as the follow-up of newborn 
being extended to one year of age. Furthermore, infants conceived with ART had 
more multiple major congenital anomalies compared with their naturally conceived 
counterparts (Hansen et al. 2002). Other studies have also shown a slightly 
increased rate of neural tube defect, alimentary atresia, omphalocele, hypospadia 
and congenital heart anomalies (ASD, VSD or transposition of the great vessels) 
among infants conceived with IVF or ICSI (Lancaster 1987; Bergh et al. 1999; Silver 
et al. 1999; Ericson and Källén 2001; Koivurova et al. 2002).
Malformation rates in both IVF and ICSI multiples are signiﬁ cantly higher than in 
IVF and ICSI singletons (Wennerholm et al. 2000; Bonduelle et al. 2002). In addition, 
a signiﬁ cantly higher malformation rate has been shown in IVF twins compared 
with ICSI twins (Bonduelle et al. 2002). It should be noted that follow-up of 
children conceived with ART is often more detailed, and thus anomalies that would 
likely have gone unnoticed in the general population might be detected in the 
ART population, elevating congenital anomaly rates in some studies (Tarlatzis and 
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Grimbizis 1999; Hansen et al. 2002).
In a recent study, no difference was observed in the rate of abnormal foetal karyotype 
among ICSI (2.9%) and IVF (3.0%) foetuses (Bonduelle et al. 2002). However, 
a small increase in sex-chromosomal abnormalities (1%) has been reported in 
many studies, which could be explained by ICSI bypassing the natural selection 
of spermatozoa and sub-optimal male gametes being used in ICSI (Bonduelle et 
al. 1996; Govaerts et al. 1996; Tarlatzis and Grimbizis 1999; Macas et al. 2001; Ola 
et al. 2001). A follow-up of 1987 children born with ICSI reported 0.83% sex-
chromosomal abnormalities, which is four times greater than the expected rate 
of 0.19% (Bonduelle et al. 1999); these results are in concordance with several 
other studies (Wisanto et al. 1996; Johnson 1998; Bonduelle et al. 1999; Tarlatzis and 
Grimbizis 1999; Macas et al. 2001; Ola et al. 2001).  A small increase in autosomal 
aberrations has also been reported (Bonduelle et al. 1999). ICSI does not increase 
the risk of chromosomal anomalies or congenital malformations, unless parents 
have an abnormal karyotype or family history of some disease (Johnson 1998), 
but the possibility of transmitting fertility problems of genetic origin to the male 
offspring cannot be excluded (Tarlazis and Grimbizis 1999), although the risk is 
marginal (Bonduelle et al. 1999, 2002).
In conclusion, the absolute risk for a serious malformation to occur after IVF 
is, according to several studies, small; however, the results of some studies are 
conﬂ icting. ICSI may marginally increase the risk of sex-chromosomal abnormalities, 
which are difﬁ cult to detect in routine examination of newborns (Ericson and 
Källén 2001). The slightly increased risk for a congenital malformation after IVF 
may partly be explained by maternal characteristics. Increased risk of hypospadia 
may be explained genetically as due to paternal subfertility, while increased risk 
of alimentary atresia might be connected to the monozygotic twinning process 
(Ericson and Källén 2001). Multiple births can increase malformation rate to some 
extent, and some malformations, such as persistent ductus arteriosus, may be related 
to premature birth (Bergh et al. 1999).
Children born after IVF in Sweden have in one large study been shown to have an 
increased risk of neurological disability, such as cerebral palsy, and an increased risk 
of developmental delay (Strömberg et al. 2002). These risks are elevated mainly due 
to the high frequency of twin pregnancies, low birthweight infants and premature 
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births among IVF children. However, long follow-up of children aged 6-13 years 
conceived with IVF revealed no difference in school performance; 92% of these 
children presented an encouraging outcome (Olivennes et al. 1997), and no large 
differences in IVF children’s psychosocial development were shown compared 
with naturally conceived children (Colpin and Soenen 2002).
The need for treatment in the neonatal care unit among IVF children is higher 
primarily due to the increased rate of preterm and multiple births (Ericson et 
al. 2002; Koivurova et al. 2002), and an increased rate of hospital care was also 
present among full-term and singleton IVF children up to an age of six years 
(Ericson et al. 2002). IVF twins did not have an excessive hospitalization rate 
compared with other twins (Ericson et al. 2002). The reported stillbirth rate is 
1.7% in ICSI and 1.3% in IVF pregnancies (Bonduelle et al. 2002). The neonatal 
death rate was, in another report, 1.0% after IVF treatment (Bustillo and Yee 
1999), but the Finnish study showed a perinatal mortality rate which was twice 
as high in IVF children compared with national ﬁ gures for the general population 
(Koivurova et al. 2002).
The postnatal growth of children born with IVF is usually normal if the neonatal 
period is uncomplicated (Wennerholm et al. 1991; Tarlatzis and Grimbizis 1999; 
Ludwig et al. 2001). No excessive risk of childhood cancer has been found after 
IVF treatment (Ericson et al. 2002). In a follow-up study of pregnancy outcome 
following cryopreserved ET, fresh IVF-ET and spontaneous pregnancies until the 
age of 5.5 years of the child, no differences were found when length, weight, 
head circumference and chronic illnesses (at 18 months of age) were compared 
(Olivennes et al. 1997; Wennerholm et al. 1998).
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1.   To assess uterine and spiral artery impedance in natural and IVF cycles 
among women with unexplained infertility compared with women with tubal 
infertility and to evaluate the usefulness of uterine artery impedance in the 
prediction of outcome of treatment and pregnancy.
2.   To compare the efﬁ cacy of ovulation induction combined with intra-uterine 
insemination, direct intraperitoneal insemination and timed intercourse in 
treatment of unexplained infertility.
3.   To study the long-term prognosis of couples with unexplained infertility.
4. To compare the obstetric outcome of treatment and spontaneous pregnancies.
III AIMS OF THE STUDY
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IV PATIENTS AND METHODS
1. Study populations and protocols (Studies I, III, IV and V).
All patients had infertility of 2-12 years in duration, normal tubal patency, normal 
semen parameters and documented ovulation. Women with minimal endometriosis 
were included in the group with unexplained infertility in studies III and IV. 
The study population and study design are shown in Tables 4 and 5.
Table 4. Study population.
Original 
 I II III IV Vpublication
Mean age 31.9 (24-38) 34.4 ± 3.8 31.3 ± 3.3 31.3 ± 3.3 33.8 ± 3.2
of women
Aetiology of unexplained tubal unexplained unexplained unexplained
infertility  endometriosis     
  unexplained
  multifactorial
     
No. of women 20 102 70 70 107
Control group 18 women with                 -                 - same women I: 445 spontanous 
 tubal infertility   with spontaneous pregnancies
    pregnancies II: 2377 IVF
     pregnancies
Treatment offered IVF IVF/ FET COH+ IUI/  COH + IUI/  IVF/ ICSI
   DIPI/ TI DIPI/ TI   
    IVF, ZIFT
No. of cycles 76 140 233 83 118
No. of cycles 38 natural and 111 IVF COH+130 IUI, 83 118
studied 38 IVF cycles 29 FET 37 DIPI, and 66 TI
   
Table 5. Study design and main outcomes in the original publications.
Original 
 I II III IV Vpublication
Purpose of To compare uterine To evaluate To compare  To study long- To study the 
study and spiral artery predictive value ovulation term fecundity and obstetric outcome 
 impedance in natural of uterine induction + compare outcome after IVF among
 and IVF cycles artery impedance IUI, DIPI and TI in spontaneous and  women with
 in two different during IVF on  treatment  unexplained 
 populations obstetric outcome  pregnancies infertility
Study design prospective prospective prospective retrospective register-based
 comparative follow-up randomized follow-up case-control
 study study study study study
Mean methods Doppler Doppler Clinical Clinical Register study
 measurement measurement study study
Main results No difference in Uterine artery Pregnancy rates: 64% conceived Obstetric
 uterine artery impedance did IUI: 7.7% during the study. outcome was
 impedance not predict DIPI: 8.1% The mean  good. An
 between the pregnancy TI: 10.7% birthweight elevated rate
 groups outcome per cycle was lower in of breech
    ART pregnancies presentation
     was found
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Study I
Twenty women with unexplained infertility and 18 women with tubal infertility, 
all scheduled for treatment with IVF (or ICSI) were recruited to participate. The mean 
age of women in the group with unexplained infertility was 32.6 (range 26-39) years, 
and in the control group 31.9 (range 24-38 years; NS). The mean (± SD) duration 
of infertility was 69 (± 32.4) months among women with unexplained infertility 
and 44 (± 16.5) months (p<0.01) among women with tubal infertility. Infertility 
was primary in 13 (65%) of the women with unexplained and in 7 (38.9%) of 
women with tubal infertility (NS). We prospectively longitudinally measured the 
uterine and spiral artery pulsatility index (PI) and peak systolic velocity (PSV) on 
cycle days 11-12, 16-17 and 21-23 in the natural cycle and on days 1, 5, 10, OPU 
and ET during the subsequent IVF cycle. The reproducibility of uterine artery PI 
measurement was assessed by calculation of the coefﬁ cient of variation (CV). CV 
was calculated by dividing the within-subject variance by the population mean. 
Variances required for the calculation of CV were estimated by ANOVA.
Study II
A total of 102 infertile women were studied on the day of ET during the IVF 
cycle or replacement cycle for frozen-thawed embryo transfer. Of these women, 56 
(55%) had tubal infertility, 13 (13%) endometriosis, 23 (22%) unexplained and 10 
(10%) were multifactorial. The mean age (± SD) of women was 34.4 (± 3.8) years. 
The uterine artery impedance (PI and RI) was prospectively evaluated one hour 
before ET and the impedance was compared with obstetric outcome in the 
conceptional cycles. Of the 111 cycles studied, 82 were fresh (IVF-ET) and 29 
frozen-thawed embryo transfers. Of these frozen-thawed ET, 20 were performed in 
natural cycles and nine in substitution cycles. In the substitution cycles, goserelin 
acetate (Zoladex; Zeneca, Macclesﬁ eld, UK), estradiol valerate (Progynova; Schering 
AG, Berlin, Germany) and natural micronized progesterone were administered. 
The predictive value of uterine artery impedance measurement for spontaneous 
abortion, ectopic pregnancy, multiple pregnancy, birthweight, relative birthweight 
and obstetric complications (IUGR, pregnancy-induced hypertension, preterm 
birth) was studied. Relative birthweight was calculated as the difference between 
actual and expected birthweight (according to sex and pregnancy duration)/ SD of 
expected birthweight.
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The uterine artery blood ﬂ ow was deﬁ ned as good if the uterine artery PI was < 3.0 
(Cacciatore et al. 1996a).
We studied 70 couples with unexplained infertility of over 2 years in duration 
during 1988-1992, including 23 women with minimal endometriosis. The mean age 
(± SD) of women was 31.3 (± 3.3 years, range 23-38). The average duration of 
infertility was 4.8 (range 2-12) years. Couples were offered superovulation treatments 
combined with IUI, DIPI or timed intercourse (totally 233 treatment cycles) and 
most couples received 1-4 treatment cycles. The stimulation protocol, pregnancy 
rate, pregnancy outcome and complications of treatment were analysed.
A follow-up study was carried out 6 (range 4-7) years later. Information regarding 
all treatment and spontaneous pregnancies was collected. Obstetric outcome 
(birthweight, rate of SGA (<-2 SD) infants and preterm births (<37 weeks), Apgar 
scores, obstetric complications and congenital malformations) was compared in 
spontaneous and treatment pregnancies. The long-term prognosis of fecundity was 
determined.
Study V
Altogether 107 women with unexplained infertility and 118 clinical pregnancies 
after treatment with IVF or ICSI during 1.1.1993-30.3.1999 were studied. These 
pregnancies resulted in 90 deliveries, of which 69 were singleton, 20 twin and 
one triplet. Twenty-eight pregnancies (23.7%) resulted in a spontaneous abortion.
The multiple pregnancy rate was 23.3%. Two different control groups for the 
deliveries and infants were chosen from the Finnish Medical Birth Register (MBR). 
One control group included spontaneous pregnancies leading to birth (comprising 
445 women and 545 children), which was matched according to year of delivery, 
woman’s  age, parity, number of foetuses and area of residence (Southern Finland). 
The other control group included all pregnancies after ART treatment leading to 
birth in Southern Finland during the study period (2377 women and 545 children). 
The following factors were studied: maternal background, use of antenatal care, 
gestational age at birth, birthweight, pregnancy and delivery complications, mode of 
delivery, major congenital anomalies, infant’s outcome and need for intensive care.
Studies III and IV
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Ovarian stimulation and preparation of spermatozoa for IUI and DIPI
(Study III)
Clomiphene citrate 50-100 mg (on cycle days 3-7) and human menopausal 
gonadotrophin 75-150 IU (on cycle days 8-10 or 5-8) was used for ovarian 
stimulation. The number of follicles was examined on day 10-12 during stimulation 
with transvaginal sonography. Typically hCG (Pregnyl) 5000-10000 IU was also 
given when the diameter of the leading follicle was at least 17 mm. Semen was 
prepared by swim-up using the husband’s semen. Sperm was gently centrifuged 
in Ham’s F 10 medium (HF 10, Gibco, Grand Island, NY, USA) supplemented with 
human serum albumin. The spermatozoa were injected in 0.5 ml of medium into 
the uterine or peritoneal cavity. Insemination was usually performed on cycle day 
13 or 14.
Ovarian stimulation for IVF and ICSI (Studies I, II, and V)
Most patients were treated with the long protocol for ovarian stimulation. 
A standardized ovarian stimulation protocol for IVF was used in all cycles. After 
pituitary down-regulation with a gonadotrophin-releasing hormone analogue, 
buserelin (Suprecur, Hoechst) or nafarelin (Synarela, Syntex), administered 
intranasally usually beginning on cycle day 21, suppression was conﬁ rmed by 
transvaginal sonography. Ovarian stimulation commenced with daily injections 
of gonadotrophins/FSH (Puregon, Organon, Oss, The Netherlands, or Gonal-F, 
Laboratories Serono,  Aubonne, Switzerland). The cycle was monitored by repeated 
serum oestradiol assays and vaginal ultrasounds. When two or more follicles were 
≥17 mm in diameter, human chorionic gonadotrophin (hCG, Pregnyl, Organon or 
Profasi, Laboratories Serono) was administered and OPU was performed 36-38 hours 
later. Embryo transfer was performed two days after follicle aspiration and luteal 
phase was supplemented with vaginally administered progesterone (Lugesteron, 
Leiras, Tampere, Finland).
In Study V, the starting dose of FSH was 100 IU in 1.7%, 150 IU in 66.1%, 200 IU in 
11.6%, 225 IU in 19.5% and 300 IU in 1.7% of cycles.
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Follow-up of IVF and ICSI pregnancies (Studies I, II and V).
If the quantitative hCG in serum was found to be positive 12 days after ET, the ﬁ rst 
ultrasound examination was performed ﬁ ve weeks after ET. A clinical pregnancy 
was deﬁ ned as a pregnancy showing a visible gestational sac upon the ultrasound 
ﬁ ve weeks after ET; no biochemical pregnancies were included in the studies.  All 
pregnancies were followed at antenatal care units. Women attended the screening 
ultrasound for examination of foetal morphology in weeks 16-18. The pregnancies 
were followed at the delivery hospital and included repeated clinical examinations, 
measurement of maternal blood pressure, urinary analysis, cervical status, foetal 
cardiotocography (usually after 30 weeks of pregnancy) and repeated ultrasound 
examinations to assess foetal growth and bioproﬁ le.
Preterm delivery was deﬁ ned as delivery before 37 completed weeks. Small for 
gestational age was deﬁ ned as a birthweight below -2 SD according to Finnish 
birthweight standards adjusted for gestational age and sex (Pihkala et al. 1989). 
Pregnancy-induced hypertension was deﬁ ned as a blood pressure of ≥140/90 
mmHg (after 20 weeks of gestation), an increase in systolic blood pressure of ≥30 
mmHg or an increase in diastolic blood pressure of ≥15mmHg (Gifford et al. 1990). 
A major congenital anomaly is deﬁ ned as a signiﬁ cant congenital structural 
anomaly, chromosomal defect or congenital hypothyroidism involved in a birth 
with congenital anomalies. This does not include hereditary diseases and other 
diseases not associated with congenital anomalies, dysfunction of organs or 
tissues, developmental disabilities, congenital infections, isolated minor dysmorphic 
features, normal variations and common less signiﬁ cant congenital anomalies, which 
are included in the exclusion list utilized by the Finnish Malformation Register 
(Stakes 2001).
The Finnish Medical Birth Register (MBR) is a statutory nation-wide register, which 
includes information on maternal background, pregnancy, delivery and perinatal 
outcome. The MBR was used to get information on pregnancies and deliveries 
and to select the two control groups (Study V). Diagnoses of malformations were 
veriﬁ ed from the Finnish Malformation Register.
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2. Hormonal assays
Estradiol was quantitated using the Immuno 1 analyser (Tarrytown, NY, USA). 
The detection limit of the assay is 37 pmol/l. Total variation is <6% at 
concentrations of 270-5300 pmol/l. For progesterone, Spectria Progesterone (125 I) 
Radioimmunoassay (Farmos Diagnostica, Turku, Finland) was used. The inter-assay 
CV is 7-9% at concentrations of 1.6-27 nmol/l.
In FET cycles, the luteinizing hormone (LH) surge was determined with home 
urinary kits (Clearplan, Unipath Limited, Bedford, England) to detect ovulation, 
and women began testing 3-4 days before expected ovulation.
HCG was analysed with an immunoﬂ uorometric assay (DELFIA, Wallac, Turku, 
Finland) 12 days after ET. Inter-assay CV is <10% in the concentration range of 
1-5000 IU/l.
 
3. Ultrasound and Doppler assessment (Studies I and II).
The examination began with inspection of the uterus and measurement of 
endometrial thickness in the antero-posterior dimension. The transducer was then 
angled to the right and left of midline in the sagittal plane to examine the number 
and size of follicles in the ovaries. The uterine vessels were located with colour 
Doppler sonography and the ascending branch was identiﬁ ed lateral to the cervix, 
at the level of the internal os. A gate was placed over the vessel, the width of the 
sample gate (2-3 mm) was adjusted according to the vessel diameter and a blood 
velocity waveform was obtained. When the signals passing the gate returned, the 
Doppler frequency shift echoes were converted electronically by a mathematical 
technique and displayed as a Doppler shift versus time waveform. The PI was 
calculated using three consecutive uniform heart beats and averaged. The mean 
value of uterine artery PI and RI/PSV from both ascending uterine artery branches 
was used in calculations.
Blood vessels in the subendometrial region were located using the Power Doppler 
and colour Doppler techniques. Areas of maximum colour intensity were selected, 
a Doppler range gate applied and the pulsed Doppler function activated to assess 
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blood ﬂ ow velocity. Peak systolic blood ﬂ ow velocity waveforms were detected.  No 
correction was made for insonation angle since the angle of insonation for small 
vessels cannot be determined (Zaidi et al. 1995).
All measurements in Studies I and II were performed between 7 and 9 a.m. 
using US equipment (model ATL HDI 5000, Seattle WA, USA, model 515A; Hitachi, 
Tokyo, Japan, or model SS-2000; Aloka, Tokyo, Japan) with 5.0-6.5 MHz transvaginal 
transducer. The high-pass Doppler ﬁ lter was set at 100 Hz. The average duration of 
the procedure was 30 minutes.
 
4. Statistical analysis
Statistical analysis of the data was performed using the Statistical Package for Social 
Sciences (SPSS 8.0.1., Chicago, IL, USA) in Studies I-IV. The SAS statistical package 
was used in Study V.
The shape of the frequency distribution of continuous variables was evaluated by 
means of histograms to determine whether or not it had a normal (symmetrical) 
or skewed distribution, and by using the Kolmogorov-Smirnov normality test. In 
normal distributed data, differences between means of the variables were assessed 
by Student’s t-test, and in data without normal distribution, differences between 
medians were assessed by the Mann-Whitney U-test. In cases of categorical data, 
statistical signiﬁ cance of differences in frequency between groups or comparisons 
between proportions were assessed using the Chi-square test. The Wilcoxon signed-
rank test and Pearson’s correlation coefﬁ cient were used to analyse associations 
between variables measured from the same patient on different days. Group 
comparisons were performed with Fisher’s exact test, test for relative proportions 
and Chi-square test, which were also adjusted by the Bonferroni method.
The level of statistical signiﬁ cance in all studies was deﬁ ned as p<0.05.
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RESULTS
1. Uterine and spiral artery blood ﬂ ow in unexplained infertility 
(Study I)
The mean resistance to blood ﬂ ow in uterine arteries measured as PI was below 
three in all women with unexplained infertility studied during both natural and IVF 
cycles, and no differences were found when comparing their results with those 
of women with tubal infertility. Uterine artery PI measurements had a mean CV 
of 7.8%. With regard to uterine artery PSV, no difference was observed between 
the groups. No difference was found in mean PI or PSV in spiral arteries when 
comparing women with unexplained infertility and those with tubal infertility, 
except on day 5 of the IVF cycle (Figure 2), when mean PI (±SD) was signiﬁ cantly 
lower (p<0.05) in the former (0.96 ± 0.25) than the latter (1.24 ± 0.30) group.
Figure 2. Comparison of spiral artery pulsatility index (PI) in women with unexplained 
and tubal infertility during spontaneous and IVF-cycles.
(n)
Values are mean ± SE. *p<0.05.
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2. Prognostic signiﬁ cance of uterine artery impedance (Study II)
No differences were found in the mean (±SD) uterine artery PI and RI between 
normal intra-uterine pregnancies (PI 2.69 ± 0.71 and RI 0.88 ± 0.06) and those 
resulting in spontaneous abortion (PI 2.71 ± 0.67 and RI 0.88 ± 0.05) or ectopic 
pregnancy (PI 2.36 ± 0.54 and RI 0.85 ± 0.06). Nor were there any differences in 
uterine artery PI and RI between women with obstetric complications (including 
IUGR, pregnancy-induced hypertension or preterm birth) with a mean PI of 2.54 ± 
0.47 and RI of 0.87 ± 0.04 compared with those with uncomplicated pregnancies 
with a mean PI of 2.74 ± 0.78 and RI of 0.88 ± 0.06. No correlation was found with 
uterine artery PI and RI and absolute or relative foetal birthweight. In singleton 
pregnancies, no difference was observed for any obstetric outcome parameters 
between cycles with PI>3.0 and PI≤3.0 (Table 6).
Table 6. Outcome of singleton pregnancies in relation to uterine artery blood ﬂ ow. Data 
presented as mean (range), mean ± SD or actual number (% of all).  Relative birthweight 
was calculated as the difference between actual and expected birthweight (according to 
sex and pregnancy duration)/ SD of expected birthweight.
Intergroup differences not statistically signiﬁ cant.
_________________________________________________________________
 PI≤3 PI>3
 (n=49) (n=14)_________________________________________________________________
Gestational age 276.9 (249-295) 277.4 (260-288)
(days)
Birthweight 3365 ± 586.9 3369 ± 493.6
(grams)
Relative birthweight -0.50 ± 1.1 -0.47 ± 1.1
Pregnancy complications 8 (16.3%) 3 (21.4%)
_________________________________________________________________
3. Comparison of ovulation induction combined with intra-uterine 
insemination, intraperitoneal insemination and timed intercourse 
(Study III)
The pregnancy rate per couple was 28.5% and 8.6% per cycle. The pregnancy 
rates per cycle were equally good with superovulation combined with IUI (7.7%), 
DIPI (8.1%) and TI (10.7%), as shown in Table 7. No differences in pregnancy rates 
were found when comparing women with primary and secondary infertility. In 
conceptional cycles, luteal phase progesterone was signiﬁ cantly higher than in non-
conceptional cycles. The serum estradiol concentration, number of follicles before hCG 
and concentration of sperm after swim-up were comparable in conception and 
non-conception cycles. The duration of infertility did not inﬂ uence the chance of 
conception. Of the pregnancies, 85% occurred during the ﬁ rst four treatment cycles 
(Table 8). The following pregnancy complications were found in the study group: 
two cases of ovarian hyperstimulation (0.9% of the cycles), one ectopic pregnancy 
(5% of the pregnancies), seven multiple pregnancies (40% of the deliveries), 
including one quintuplet pregnancy (5% of the pregnancies). In this pregnancy, 
a selective fetal reduction was performed, and the pregnancy continued until week 
34 of gestation when healthy twins were born.
Table 7. Outcome of treatment with superovulation in combination with insemination 
or timed intercourse.
_______________________________________________________________________
 Intrauterine Direct Timed
 insemination intraperitoneal intercourse
  insemination
_______________________________________________________________________
Number of cycles 130 37 66
Number of pregnancies 10 3 7
Delivery 7 3 5
      singleton 4 2  3
      twins  3 1 2
Spontaneous abortion 2  - 2
Ectopic pregnancy 1  - -
Pregnancy rate per 7.7 8.1 10.7
treatment cycle (%)
 _______________________________________________________________________
Table 8. Relation between number of treatment cycle and pregnancy rate.
_______________________________________________________________________________
 Cycle number No. of No. of Total no. of
  patients pregnancies pregnancies
_______________________________________________________________________________
 1 62 5 5
 2 52 6 11
 3 42 4 15
 4 32 2 17
 5 22 1 18
 6 15 1 19
 7 5 1 20
 8 2 0 20
 9 1 0 20_______________________________________________________________________
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4. Course of ART-induced and spontaneous pregnancies
(Studies IV and V)
The treatment pregnancies in Study IV included pregnancies achieved with 
ovulation induction alone or in combination with IUI/ DIPI or IVF. Table 9 
shows the respective rates of spontaneous abortion, ectopic pregnancies and 
multiple pregnancies. Among singletons, the mean gestational duration was 39.6 
weeks in treatment-related pregnancies, which was similar to that of spontaneous 
pregnancies. The mean birthweight (±SD) of singletons was 3120 g (± 488) in 
treatment-related pregnancies and 3387 g (± 470) in spontaneous pregnancies 
(p<0.05). Table 10 shows a comparison of perinatal outcome in spontaneous and 
treatment-related singleton pregnancies. In singletons, no difference was observed 
in the rate of preterm delivery or small-for-gestational-age babies. Among women 
with treatment-related twins and those with spontaneous twins, 66.7% and 100%, 
respectively, were delivered preterm (NS). The rates of congenital anomalies were 
18.2% in treatment related and 10% in spontaneous pregnancies (NS).
After IVF/ ICSI treatment, the rate of spontaneous abortion was 23.7% (Study V). 
The multiple pregnancy rate was 23.3%, and all but one were twin pregnancies. 
One triplet pregnancy that resulted from a two-embryo transfer occurred, and the 
children were born healthy in week 33 of gestation.
Among singleton pregnancies, no difference was found in the mean birthweight, rate 
of low birthweight (<2500 g) or very low birthweight (<1500 g) when comparing 
the study group and control groups, as shown in Table 11. Nor were differences 
found in gestational duration, major congenital malformations or perinatal mortality 
among the groups studied. However, among singletons in the study group, more 
term breech presentations (10.1%) occurred as compared with both spontaneously 
conceiving women and all IVF women (p<0.01). The rate of pregnancy-induced 
hypertension was signiﬁ cantly lower among singletons in the study group (p< 0.05) 
compared with other IVF singletons.  Among study group singletons, the rate of 
Caesarean section was 24.6%, which was comparable with the rates of control 
groups.
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Table 9 . Comparison of pregnancy outcome in spontaneous and treatment-related
pregnancies in women with unexplained infertility. Data presented as % of all.
_______________________________________________________________
 ART Spontaneous
 group pregnancy group
_______________________________________________________________
Multiple pregnancies 25.0 2.8  *
Spontaneous abortion 21.2 10.0  NS
Ectopic pregnancies 6.1 8.0  NS
_______________________________________________________________
* p< 0.05
Table 10.  Comparison of perinatal outcome in spontaneous and treatment-related 
singleton pregnancies.
_____________________________________________________________________________
 Spontaneous Treatment-related
 pregnancies pregnancies
  (n=35) (n=18)
_____________________________________________________________________________
Mean gestational duration (days) 276.4 277.4
Preterm birth 1/35 (2.9%) 1/18 (5.5%)
(<37 weeks of gestation)
Mean birthweight ± SD (grams) 3387 ± 470 3120 ± 488 *
Relative birthweight -0.33 -0.97  **
Mean 1 min Apgar score 8.7 8.7
Small for gestational age (<- 2 SD) 1/35 (2.9%) 2/18 (11.1%)
Perinatal mortality (%) 0.0 0.0
Congenital anomalies of newborn (%) 
_____________________________________________________________________________
*p<0.05 **p<0.01.
5.7 5.5
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Table 11. Outcome of singleton IVF pregnancies in women with unexplained infertility. 
Intergroup differences not statistically signiﬁ cant.
_____________________________________________________________________________
 Study group Control Control 
  group I group II
 (n=69) (n=345) (n=1901)
_____________________________________________________________________________
Mean duration of gestation 39.3 39.7 39.4
(weeks)
Preterm birth (< 37 weeks ; %) 5.8 10.1 6.8
Mean birthweight 3425 3438 3468
(grams + SD)  (± 621) (± 572) (± 593)
Birthweight
<1500g (%) 1.5 0.0 1.2
<2500g (%) 2.9 5.8 5.0
SGA (%) 2.9 2.9 2.4
Mean 1 min Apgar score  8.7 8.8 8.7
Apgar score 0-3 (%) 4.3 1.4 1.4
                       4-6 (%) 0 1.4 2.3
                      7-10 (%) 95.7 97.1 96.2
Mean umbilical arterial pH 7.24 7.24  7.25
ph< 7.10 (%) 1.5 4.3 1.9
pH< 7.20 (%) 10.1 11.6 11.9
Perinatal mortality (%) 1.5 1.5 0.7
Congenital anomalies  7.2 3.5 4.4
of newborn (%)
_____________________________________________________________________________
The obstetric outcome of the IVF twins among women with unexplained infertility 
was similar as in both control groups. The rates of major congenital anomalies were 
7.2% among singletons and 2.5% among twins, which were comparable with both 
control groups.
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VI DISCUSSION
1. Uterine and spiral artery impedance among women with 
unexplained infertility
Evidence suggests that uterine artery blood ﬂ ow may be a factor affecting 
successful implantation. Studies conducted among unselected infertile women both 
in spontaneous and IVF cycles have shown poor implantation rates when the 
uterine artery pulsatility index is over 3.0-3.3 or when there is an absence of end 
diastolic velocities in the uterine artery Doppler velocity waveform (Coulam et al. 
1994; Cacciatore et al. 1996a). All patients suffering from unexplained infertility 
enrolled in our study had normal resistance to blood ﬂ ow, i.e. PI below 3, at 
all points during the spontaneous and IVF cycles. No differences in uterine 
artery impedance were observed during the spontaneous or the IVF cycle when 
women with unexplained and tubal infertility were compared. Therefore, under the 
conditions of our study, uterine blood ﬂ ow was not reduced among women with 
unexplained infertility.
Some earlier studies have postulated that abnormal uterine perfusion might be 
a contributing factor in unexplained infertility (Goswamy et al. 1988; Kupesic and 
Kurjak 1993; Steer et al. 1994). Increased uterine artery impedance in midluteal 
phase (Steer et al. 1994) and abnormal ﬂ ow in spiral arteries have been suggested 
as possible mechanisms for infertility in these women (Kupesic and Kurjak 1993). 
But very few earlier studies have been conducted on uterine artery blood ﬂ ow 
among women with unexplained infertility. Steer and co-workers studied uterine 
artery pulsatility index in 35 women with unexplained infertility as well as in 
other subgroups of infertility. Limitations of their study were, however, that Dopper 
assessments were only performed on day 21 of the unstimulated cycle and that 
no evaluation of spiral artery impedance was conducted. The main results of their 
study were in accord with our ﬁ ndings; no signiﬁ cant differences were observed in 
the median PI for patients with different causes of infertility, although women in 
all categories of infertility had signiﬁ cantly higher PI than healthy women. Kupesic 
and Kurjak (1993) investigated both natural and stimulated cycles, and also studied 
spiral artery impedance, in contrast to the above-mentioned study. The spiral artery 
PI was shown to be signiﬁ cantly lower in unstimulated cycles than in hormonally 
stimulated cycles. Limitations of this study were, however, that only patients with 
male factor infertility were included as a study group and that ovarian stimulation 
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was performed with three different stimulation protocols: CC, CC combined with 
hMG and hMG alone. Therefore, no direct comparison of results can be made 
between their study and ours.
However, the results of Tinkanen and co-workers (1994) are in accord with our 
results. In their study, the mean uterine artery PI was also normal among women 
with unexplained infertility, both in the pre- and post-ovulatory period. In contrast 
to our study, they showed that 15% of these women had a uterine artery PI over 2.8, 
which was higher than among healthy women with no history of infertility. The use 
of clomiphene citrate has also been shown to decrease the uterine blood ﬂ ow in 
the peri-implantation period among women with unexplained infertility (Hsu et al. 
1995). In addition, another earlier study (Groutz et al. 1997) showed that the uterine 
artery RI on day of hCG of the IVF cycle was signiﬁ cantly higher in this patient 
group as compared with women with tubal infertility. Our ﬁ ndings differ slightly 
from these studies. However, it is difﬁ cult to compare results because these studies 
had different stimulation protocols and different days of Doppler measurement.
Furthermore, the information obtained from the study by Ziegler and co-workers 
(1999) is limited because Doppler measurements were performed only among 
healthy nulliparous women during natural cycles and they failed to measure spiral 
artery impedance. Their study population also included both white and Asian 
women. The study by Coulam and co-workers (1994), in addition to including IVF 
cycles, also examined FET, COH, natural cycle-IUI and ovum donation cycles, and 
therefore, their results are difﬁ cult to interpret. By contrast to the above studies, 
our study protocol was new, with longitudinal evaluation of both uterine and spiral 
artery impedance in women with unexplained infertility, with women with tubal 
infertility serving as a control group.
Poor endometrial blood ﬂ ow has in some studies predicted poor implantation 
rate (Zaidi et al. 1995; Yang et al. 1999). Impedance to blood ﬂ ow in the uterine 
or spiral artery did not differ in women conceiving with IVF-ET compared with 
the other women in our study. We did show that spiral artery PI on the 5th 
day of gonadotrophin stimulation was signiﬁ cantly lower among women with 
unexplained infertility than among those with tubal infertility; however, on all 
other days, the spiral artery impedance was comparable with the control group. 
In addition, clinical pregnancy rates were comparable between these two groups: 
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40% for women with unexplained infertility and 33.3% for women with tubal 
infertility, and therefore, it seems unlikely that the difference observed in spiral 
artery impedance at the beginning of the IVF cycle would have clinical signiﬁ cance. 
We cannot exclude the possibility that this is a purely chance ﬁ nding.  As far as 
we are aware, no earlier studies have focused on spiral artery impedance among 
women with unexplained infertility. In conclusion, increased uterine or spiral 
artery impedance is likely not an important factor in unexplained infertility since 
no differences were found between the two study groups, neither during the 
spontaneous nor during the IVF cycle, with the exception of day 5 of stimulation.
2. Prediction of pregnancy outcome with uterine artery impedance 
measurement
Comparing unexplained infertility and tubal infertility, we found no difference in 
implantation rates during IVF treatment. Furthermore, no differences were present 
in uterine or spiral artery impedance when comparing women who conceived with 
IVF-ET with those who did not. Earlier studies are in concordance with this ﬁ nding 
(Tekay et al. 1995). However, this observation is in contrast to earlier ﬁ ndings by 
ourselves and other research groups, which show signiﬁ cant differences in uterine 
artery impedance between conception and non-conception cycles (Coulam et al. 
1994; Tinkanen et al. 1994; Cacciatore et al. 1996a, 1996c). However, as all women 
in our study had haemodynamic parameters within the normal range, this is not 
a surprise. One reason for these ﬁ ndings may be the limited size of the study 
population.
This is the ﬁ rst study in which preconceptional uterine blood ﬂ ow and subsequent 
pregnancy outcome have been related. Uterine artery PI and RI were unrelated to the 
risk of spontaneous abortion or ectopic pregnancy. It seems that pre-implantation 
uterine artery impedance does not inﬂ uence trophoblast formation or placental 
development. Uterine artery impedance was of no value in prediction of IUGR, 
PIH or preterm birth among unselected infertile patients. Some studies have shown 
that uterine and spiral artery resistance were lower at the end of the 5th week 
in blighted ovum pregnancies (Alﬁ revic and Kurjak 1990), and the uterine artery 
RI was lower in missed abortion compared with women with normal pregnancies 
(Alﬁ revic and Kurjak 1990; Kurjak 1994). Uterine artery PI measurement at 12-13 
weeks of gestation has been shown to predict subsequent hypertensive disorders, 
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SGA fetuses and gestational diabetes during pregnancy (van den Elzen et al. 1995). 
However, uterine artery impedance measurements during the ﬁ rst trimester in other 
studies have not predicted pregnancy outcome (Frates et al. 1996). By contrast, 
several studies show that the measurement of uterine artery blood ﬂ ow in the 
second and third trimesters may be valuable in predicting obstetric complications 
(Strigini et al. 1995; Hofstaetter et al. 1996).
3. Treatment options of women with unexplained infertility
Ovulation induction in combination with insemination or timed intercourse was 
an effective treatment for couples with unexplained infertility. The pregnancy rates 
were equally good (7.7-10.7%) per cycle in all three treatment groups. Our results 
are comparable with other studies reporting pregnancy rates of 8.7-15.3% per 
cycle (Mascarenhas et al. 1994; Nuojua-Huttunen et al. 1999a; Sahakyan et al. 1999; 
Goverde et al. 2000). Because the spontaneous pregnancy rate is 1-2% per cycle 
among couples with unexplained infertility (Hughes et al. 2001), our ovulation 
induction treatment must be considered satisfactory. No pregnancies began with 
ovulation induction in the group of women aged over 36 years. The duration of 
infertility did not inﬂ uence the chance to conceive with this treatment. The majority 
(85%) of the pregnancies began during the ﬁ rst four treatment cycles, which is 
in concordance with other studies (Nuojua-Huttunen et al. 1999a; Aboulghar et al 
2001), reporting most pregnancies to occur within the ﬁ rst three or four treatment 
cycles. Several studies have demonstrated an improvement in pregnancy rates with 
the addition of IUI to the ovulation induction protocol (Chaffkin et al. 1991; Guzick 
et al. 1998), in contrast to our results. However, according to our ﬁ ndings and other 
studies no more than three to four ovulation induction cycles can be recommended 
before proceeding to IVF (Aboulghar et al. 1999; Nuojua-Huttunen et al. 1999a; 
Sahakyan et al. 1999; Goverde et al. 2000).  The age of the woman is important 
when deciding on the number of ovulation induction cycles and when selecting 
the treatment schedule, consistent with other studies (Figure 3; Guzick et al. 1998; 
Aboulghar et al. 1999; Sahakyan et al. 1999; Goverde et al. 2000). In the ovulation 
induction cycles studied, the serum estradiol concentration, the number of follicles 
and the concentration of sperm after swim-up were similar in conception and non-
conception cycles.  The only predicting factor for conception appeared to be the 
luteal phase progesterone concentration, which was signiﬁ cantly higher in these 
cycles.
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The clinical pregnancy rate was 40% per cycle with IVF treatment among women 
with unexplained infertility. This pregnancy rate is higher than usually reported in 
Europe (Nygren and Nyboe Andersen 2001). Therefore, the prognosis for women 
with unexplained infertility to achieve a pregnancy is good, both with ovulation 
induction and with IVF.  We recommend three cycles with ovulation induction 
before proceeding to IVF.  In addition, a cautious low-dose FSH treatment schedule 
is recommended in ovulation induction.
4. Long-term prognosis of couples with unexplained infertility
Long-term fertility prognosis in unexplained infertility is favourable. Of the 70 
couples studied, 45 conceived and 83 pregnancies began. The long-term pregnancy 
Figure 3.  Management of couples with unexplained 
infertility after completed infertility evaluation. 
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rate was 64% per couple during the follow-up period and as many as 60% of the 
pregnancies began spontaneously after completed ovulation induction treatment. 
Of the women studied, 31% achieved two pregnancies or more during the follow-
up. Infertility treatment that resulted in pregnancy included IVF (n=10), CC (n=1), 
ovulation induction combined with IUI (n=12), DIPI (n=3) and TI (n=7). These 
ﬁ ndings are in agreement with earlier life table analyses, which have shown that 
many couples with unexplained infertility will ultimately conceive also without 
treatment (Collins et al. 1983; Fish et al. 1989; Jaffe and Jewelewicz 1991). Duration 
of infertility of more than three years has in several earlier studies been the 
major negative prognostic factor (Levene et al. 1992; Crosignani et al. 1993), but 
in our study, the duration of infertility did not inﬂ uence the couple’s chances of 
conception. The pregnancy rates were also equally good in women with primary 
and secondary infertility. Therefore, many couples with unexplained infertility 
do ultimately conceive but do so over a longer period of time than the fertile 
population.
5. Obstetric outcome of couples with unexplained infertility
The rate of spontaneous abortion was similar with ovulation induction (20%) and 
IVF (23.7%). The ectopic pregnancy rate was 5% after ovulation induction and 0% 
after IVF, these ﬁ gures being within the normal variation of rates reported earlier. 
Multiple pregnancy rate was slightly higher after COH (30%) than after IVF (23.3%). 
Our multiple pregnancy rate after COH was higher than in another report from 
Finland, which claimed a multiple pregnancy rate of only 17% (Nuojua-Huttunen 
et al. 1999b). However, the multiple pregnancy rate with IVF was similar to 
other reports from Europe (Nygren and Nyboe Andersen 2001). The intensity 
of stimulation used for COH is related to the multiple pregnancy rate. Our 
treatment protocol for COH included CC combined with hMG, yielding mostly 
5-6 preovulatory follicles. Today, low-dose FSH is preferred, which results in 1-2 
preovulatory follicles. Milder stimulation protocols can achieve similar success rates 
with a lower proportion of twins. Therefore, stimulation has become more cautious 
in recent years, using lower doses of gonadotrophins. In our clinic, the multiple 
pregnancy rate has also decreased since this study was conducted.
Only a few studies have been carried out to evaluate possible differences in 
pregnancy complications in different infertility subgroups. Pregnancies achieved 
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with superovulation did not carry an increased risk of obstetric complications, 
other than a slightly reduced birthweight and a relatively high rate of multiple 
pregnancies. The malformation rate after COH seems higher than in another Finnish 
report (Nuojua-Huttunen et al. 1999b). One reason for this difference might be 
a different classiﬁ cation of malformations. After IVF, no difference was observed 
when comparing the malformation rates with the control groups. Moreover, 
obstetric outcome of IVF pregnancies after unexplained infertility was good, with 
no differences in mean birthweight, gestational duration, Caesarean section or 
perinatal mortality when compared with the control groups. IVF twins had a 
similar obstetric outcome as spontaneously conceived twins. This is in contrast 
with a recent study showing that IVF twins had lower average birthweights than 
spontaneously conceived twins (Koudstaal et al. 2000b). We found signiﬁ cantly less 
pregnancy-induced hypertension (0%) among singletons of the study group than 
among other IVF pregnancies, and signiﬁ cantly more term breech presentation 
(10%) compared with both control groups; as far as we are aware, such ﬁ ndings 
have not been reported earlier. Another recent report showed an increased rate 
of pre-eclampsia, placental abruption and preterm labour among women with 
unexplained infertility, which is also in contrast to our results (Pandian et al. 2001). 
Obstetric interventions, including Caesarean section and induction of labour, were 
more common in their study. In addition, while an increased rate of IUGR has 
been shown among women with unexplained infertility (Wang et al. 1994; Dawood 
1996), our ﬁ ndings do not support this. However, in pregnancies after ovulation 
induction, the mean birthweight was lower than in spontaneous pregnancies. No 
differences were observed after IVF treatment when mean birthweight, incidence 
of low birthweight or very low birthweight babies among women with unexplained 
infertility were compared with those of spontaneously conceived pregnancies. 
Therefore, according to our results, the obstetric outcome of pregnancies among 
women with unexplained infertility is promising and generally comparable with 
spontaneous and ART pregnancies. The only factor affecting pregnancy outcome 
adversely is the increased risk of multiple pregnancies after ART treatment, which 
can be reduced by low-dose gonadotrophin stimulation and by the transfer of 
a single embryo in IVF cycles.
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VII SUMMARY AND CONCLUSIONS
1.  Uterine artery and spiral artery impedance were low during both natural 
and stimulated cycles in women with unexplained infertility and were 
comparable with the results of women with tubal infertility. Therefore, under 
the conditions of our study, uterine artery impedance does not appear to 
be an important factor in the aetiology of unexplained infertility. Predicting 
obstetric complications and outcome with measurement of uterine artery 
impedance during IVF treatment was not possible. Pre-implantation uterine 
artery impedance evidently has no inﬂ uence on trophoblast formation or 
placental development.
2.  Treatment with superovulation combined with IUI, DIPI and TI were all good 
treatment options for unexplained infertility, with similar pregnancy rates of 
approximately 9% per treatment cycle and 28.5% per couple and limited 
treatment complications.
3.  The long-term pregnancy rate was good, with 64% of women conceiving; 
the majority of pregnancies during follow-up began spontaneously. Expected 
management can therefore be considered if the woman is young (<30 years) 
and duration of infertility has been short (<2 years).
4.  Obstetric outcome of IVF pregnancies, both singletons and twins, was good 
among women with unexplained infertility. Birthweight, gestational duration 
and major congenital malformation rates were comparable with those of 
spontaneous pregnancies. Therefore, IVF treatment in this patient group seems 
to be a good option when treatment with ovulation induction has failed. 
The only factor affecting pregnancy outcome is an increased risk of multiple 
pregnancies, which can be reduced by the transfer of a single embryo in 
selected cases.
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